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Abstract 
The identities of stem cells and their differentiated progeny are controlled by 
transcription factor networks that interact with chromatin modifying enzymes to package 
the genome into active and repressed domains. These transcription factor networks 
maintain stem cell identity across numerous rounds of self-renewing division through 
extensive auto- and feedforward-regulation, and by activating genes that are important 
for stem cell function. In addition, stem cell transcription factor networks directly regulate 
pro-differentiation genes, which are maintained in a poised chromatin state by the 
Polycomb group (PcG) and Trithorax group (TrxG) of chromatin modifying enzymes. 
How transcription factor networks maintain the poised chromatin state in stem cells, and 
coordinate the transition to an active chromatin state in their differentiating progeny 
remains unclear, and how this translates into the restriction of developmental potential 
is completely unknown.  
To elucidate mechanisms that regulate stem cell self-renewal and differentiation 
my thesis work focuses on a subset of neural stem cells in the fly larval brain, called 
type II neuroblasts, and their production of intermediate neural progenitors (INPs). Type 
II neuroblast identity is maintained by a core group of self-renewal transcriptional 
repressor proteins including Klumpfuss, Deadpan and E(spl)my, as well as lineage-
specific transcriptional activators including Pointed-P1 and Buttonhead that endow type 
II neuroblasts with the competence to produce INPs. My work demonstrates that 
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earmuff (erm) is specifically expressed in immature INPs, and functions as the master 
regulator of INP commitment, restricting their competence to respond to members of the 
self-renewal network by acting as a transcriptional repressor. In addition, we find the 
self-renewal transcriptional repressor network, lineage-specific transcriptional activators, 
and PcG and TrxG proteins converge to maintain the erm locus in a poised chromatin 
state in type II neuroblasts. Following asymmetric division, selective down-regulation of 
self-renewal transcriptional repressors in the immature INP allows rapid activation of 
erm expression. Erm then ensures stable commitment to a restricted INP identity by 
directly repressing components of the neuroblast transcription factor network. We 
propose the use of similar poised negative feedback circuits as a universal mechanism 
to balance continual self-renewal and rapid restriction of developmental potential across 
asymmetric stem cell division. 
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Chapter 1: Introduction 
Stem cells are broadly defined by two cardinal features: (1) the ability to undergo long 
term self-renewal to maintain their own identity across numerous rounds of division, and 
(2) multipotency, meaning they have the capacity to give rise to a variety of more 
restricted or differentiated cell types. Thus, the term “stem cell” has become a catch-all 
in biology to refer to a variety of cells that differ greatly in their developmental potential. 
Embryonic Stem (ES) cells populate the inner cell mass (ICM) of the blastocyst and 
possess an extremely wide developmental potential, ultimately giving rise to cells within 
all three germ layers of the developing embryo. In comparison, tissue specific stem cells 
possess a more restricted developmental potential, and are responsible for generating 
and replenishing the specialized differentiated cell types within the tissues they reside 
(including the blood, gut, brain, and germline) throughout lifespan. Due to their potential 
use in regenerative medicine, stem cells have garnered immense interest in the medical 
and scientific communities. In addition, accumulating evidence suggests that numerous 
types of cancer arise from stem cell lineages that have acquired mutations which limit 
their differentiation programs. Realizing the immense therapeutic potential of stem cell 
biology requires an in-depth understanding of the mechanisms that control their self-
renewal and differentiation. Here we discuss advances toward elucidating the molecular 
mechanisms controlling these cellular processes in both ES cells and tissue specific 
stem cells, as well as some of the current limitations in our understanding. In addition,
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we discuss the regulation of neural stem cells in the fruit fly Drosophila to emphasize 
how studies of this relatively simple model organism may address some of the 
remaining enigmas in the field of stem cell biology. 
The intimate relationship between gene regulation and stem cell biology.  
All of the information essential for producing the diverse cell types that comprise 
metazoan organisms, including both stem cells and their progeny, is precisely encoded 
within the sequence of the genome. Although almost all cells within an organism contain 
a full complement of the genome, individual cell types only utilize, or express, a subset 
of the information their genome encodes. Thus, establishment and maintenance of 
specific cellular identities requires precise organization of the genome into active and 
repressed domains. This is achieved in part by wrapping the DNA around core 
octamers of proteins called histones to form nucleosomes. These nucleosome subunits 
are then chemically modified by large protein complexes known as chromatin modifiers 
to partition the genome into distinct domains, and establish the secondary chromatin 
structure (Sexton and Cavalli, 2015). However, few chromatin modifiers have the 
capacity to bind specific regions of the DNA on their own. Rather, recruitment of 
chromatin modifying enzymes to specific sites in the genome is often achieved through 
physical interaction with sequence specific transcription factor proteins that typically 
recognize short (6-10bp) motifs within the DNA. These motifs can occur by chance in 
the genome, potentially resulting in noisy or inappropriate transcription factor binding, so 
functional transcription factor binding elements often contain clusters of several binding 
sites in close proximity to one another. In addition, the open or closed state of the 
chromatin at particular regions of the genome can also determine which motifs a 
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transcription factor will actually bind in a given cell type (Lupien et al., 2008; McKay and 
Lieb, 2013; Teytelman et al., 2009).  Ultimately, decoding the information contained in 
the sequence of the genome into specific cellular expression patterns is achieved 
through a complex interaction of the chromatin state, transcription factor binding and 
recruitment of chromatin modifying enzymes. Thus, understanding stem cell biology 
requires an in depth knowledge of the transcription factor networks they express, and 
how these networks interact with chromatin modifying enzymes to both maintain the 
chromatin state during self-renewal, and re-organize the chromatin during the 
generation of more restricted cell types.   
Self-propagating transcription factor network maintain stem cell identity across 
self-renewing division.  
Extensive investigation of mammalian ES cells and tissue-specific stem cells has 
revealed their self-renewal is dependent on intricate transcription factor networks. 
Although the networks that maintain the identity of distinct stem cell populations are 
comprised of unique, sometimes partially over-lapping, collections of transcription 
factors, the overall network architecture and regulatory logic appears to be very similar 
between stem cell types.  Genome-wide association studies indicate stem cell 
transcription factors often bind their own distal- and proximal- cis-regulatory elements, 
called enhancers and promoters respectively, as well as cis-regulatory elements of 
other stem cell transcription factors (Boyer et al., 2005; Kim et al., 2008; Loh et al., 
2006; Mateo et al., 2015; Schütte et al., 2016; Wilson et al., 2010). Furthermore, these 
transcription factors also share numerous additional common targets, including genes 
important for stem cell identity (i.e. chromatin modifiers and cell-signaling genes). Thus, 
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Figure 1: Stem cell transcription factor networks 
balance self-renewal and differentiation. Illustration of a 
hypothetical stem cell transcription factor network. Altering 
the activity of this network shifts the balance from self-
renewal to differentiation. Small colored balls: transcription 
factors.  
two of the defining features 
of stem cell transcription 
factor networks are: (1) they 
are self-propagating, 
engaging in extensive auto- 
and feedforward-regulation 
to maintain their own 
expression across numerous 
rounds of self-renewing 
division, and (2) they function 
cooperatively to maintain the 
activation of numerous 
genes required for stem cell 
function (Figure 1).  
Stem cell transcription 
factor networks prime the 
genome for lineage commitment and differentiation.  
In addition to binding the regulatory regions of genes involved in self-renewal, stem cell 
transcription factors networks also bind the enhancers and promoters of genes that 
control the subsequent lineage commitment and differentiation of stem cell progeny 
(Boyer et al., 2005; Kim et al., 2008; Loh et al., 2006). This was initially suggested to 
imply a context dependent role of stem cell transcription factor networks to activate self-
renewal genes and repress differentiation genes; however, several lines of evidence 
5 
    
indicate an alternative scenario. While overexpression of certain components of the 
stem cell transcription factor network enhances self-renewal capacity (Chambers et al., 
2003; Kim et al., 2008; Martello et al., 2013; Nichols and Smith, 2009), others induce 
stem cells to prematurely differentiate into distinct, more restricted cell types (Kopp et 
al., 2008; Niwa et al., 2000; Zhao et al., 2004). Although it’s possible the pro-
differentiation effect of this second class of stem cell transcription factors is a non-
physiological artifact of overexpression, this is unlikely. During development, distinct 
components of stem cell transcription factor networks remain active in the lineage 
restricted or differentiated cell types they produce, and contribute to their respective 
cell-fate choices (Figure 1)  (Heinz et al., 2010; Imayoshi and Kageyama, 2014; 
Novershtern et al., 2011; Weidgang et al., 2016). Thus, the unique collection of 
transcription factors that maintain the identity of a given stem cell type likely establishes 
their fixed developmental potential by priming their genome for the generation of 
specific differentiated cell types. This suggests maintenance of stem cell identity likely 
depends on an intricate balance between components of the transcription factor 
network to prevent premature activation of their pro-differentiation targets. Shifting this 
balance likely contributes to the precise timing and directionality of differentiation 
(Figure 1). Ultimately, elucidating how stem cell transcription factor networks control 
self-renewal and differentiation requires continued investigation of (1) the functional 
consequence of specific transcription factor binding events on their pro-differentiation 
targets (i.e. activation vs. repression), and (2) the mechanisms that selectively alter the 
activity of components of these networks in stem cell progeny.  
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Regulation of the chromatin state by Polycomb and Trithorax group proteins.  
By modulating the accessibility of the genome to transcription factor binding, the 
chromatin state of a given cell type influences the functional output of their transcription 
factor network. The Polycomb group (PcG) and Trithorax group (TrxG) of proteins are 
chromatin modifying enzymes that play a central role in organizing the genome into 
active and repressed domains, as well as the heritable propagation of these 
transcriptional states across cell division.  
  PcG and TrxG genes were originally identified by genetic studies in Drosophila 
based on their common homeotic mutant phenotypes in which anterior-posterior 
patterning is disrupted (Ingham, 1998; Kennison, 1995).  Extensive genetic analysis 
eventually revealed the homeotic mutant phenotype of PcG and TrxG genes is the 
result of mis-regulation of Hox genes in the Bithorax Complex (BX-C) (Ingham, 1983). 
Mutation of PcG genes results in de-repression of components of the BX-C, leading to 
ectopic expression within segments along the anterior-posterior axis. Conversely, TrxG 
genes are required for both the normal and ectopic activation of the BX-C (Ingham, 
1983). This analysis led to the prevailing “red-light/green-light” model of gene regulation 
by PcG and TrxG proteins, in which these complexes work antagonistically to one 
another, mediating repression versus activation of their common target genes 
respectively (Geisler and Paro, 2015; Piunti and Shilatifard, 2016).  
Genetic identification and cloning of PcG and TrxG proteins enabled biochemical 
analysis of these complexes which demonstrated their function as chromatin modifying 
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Figure 2: PcG and TrxG proteins functions 
as chromatin modifying enzymes to 
establish and maintain active and repressed 
genomic domains.  
enzymes. The purification of PcG 
genes showed they comprise two 
distinct complexes: (1) Polycomb 
Repressive Complex 1 (PRC1), which 
contains the core subunits Polycomb 
(Pc), Posterior sex combs, dRing1, and 
Polyhomeotic, and (2) Polycomb 
Repressive Complex 2 (PRC2), which 
contains the core subunits Extra sex 
combs, Enhancer of zeste (E(z)), and Suppressor of zeste 12 (Su(z)12) (Figure 2) 
(Müller et al., 2002; Saurin et al., 2001; Shao et al., 1999). PRC1 catalyzes mono-
ubiquitination of lysine 119 on histone 2A (H2AK119ub) though its Ring1 E3 ubiquitin 
ligase subunit (Figure 2) (Wang et al., 2004). PRC2 also functions as a chromatin 
modifying complex, and catalyzes methylation of lysine 27 on histone 3 (H3K27me) 
(Figure 2) (Müller et al., 2002). PRC2 is the sole H3K27 methyltransferase in Drosophila 
and vertebrates, catalyzing mono-, di-, and tri-methylation of H3K27 (Ferrari et al., 
2014). Regions of the genome associated with prolonged PRC2 occupancy, and PRC2 
mediated repression, are primarily marked by H3K27me3 (Ferrari et al., 2014).  
Interestingly, the PRC1 component Pc can bind to PRC2-deposited H3K27me3 through 
its chromodomain, and this interaction is important for recruiting PRC1 to specific sites 
in the genome (Figure 2) (Min et al., 2003). In addition, PRC2 has an increased affinity 
for nucleosomes bearing H2AK119ub, and this interaction stimulates the H3K27 
methyltransferase activity of PRC2 in vitro (Figure 2) (Blackledge et al., 2014). The 
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reciprocal interaction of PRC1 and PRC2 with their modified histone substrates provides 
a biochemical explanation for their co-occupancy of numerous target loci in the genome, 
and their cooperation during gene regulation (Blackledge et al., 2015). In addition, this 
suggests PcG genes may be able to propagate their own interaction with specific 
regions of the genome, and may partially explain the heritable nature of PcG regulated 
domains (Steffen and Ringrose, 2014).   
 The Drosophila genome encodes three known H3K4 methyltransferases 
including Trithorax (Trx), Set1, and Trithorax-related (Piunti and Shilatifard, 2016). Set1 
is responsible for global di- and tri-methylation of H3K4 (Ardehali et al., 2011), whereas 
the role of Trx appears to be more nuanced (Mohan et al., 2011). Although Trx 
catalyzes methylation of lysine 4 on histone 3 (H3K4me) in vitro (Tie et al., 2014), 
reducing the activity of Trx does not have a dramatic effect on global H3K4 methylation 
(Mohan et al., 2011). Thus, it is likely that Trx mediates a subset of H3K4 methylation in 
the genome (Figure 2). Consistent with this model, Trx is recruited to specific regions of 
the Drosophila genome, such as the BX-C, through interactions with Trx response 
elements (TREs), and is required for transcriptional activation of these genes (Ringrose 
and Paro, 2007). The vast majority of the TREs that have been molecularly defined in 
Drosophila occur in close proximity to Polycomb response elements (PREs), suggesting 
the TrxG proteins may have a specific role during the activation of PcG regulated genes 
(Figure 2) (Ringrose and Paro, 2007).  
The role of Polycomb and Trithorax group proteins during stem cell regulation 
The PcG and TrxG proteins are highly conserved in mammals, and in addition to their 
conserved role in regulating anterior-posterior patterning they also contribute to the 
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regulation of stem cell biology (Aloia et al., 2013; Luis et al., 2012; Sauvageau and 
Sauvageau, 2010). Genome-wide association studies in human and mouse ES cells 
found PRC2 binds the Hox gene clusters as well as a large number of additional 
transcription factors that function as master regulators of lineage commitment and 
differentiation in the developing embryo (Boyer et al., 2006; Lee et al., 2006d). 
Consistent with direct regulation by PRC2, the local chromatin of these genes was 
enriched with H3K27me3, and mutation of EED, the vertebrate homologue of 
Drosophila extra sexcombs, results in de-repression of multiple PRC2 targets in mouse 
ES cells (Boyer et al., 2006). Thus, it was suggested PRC2 promotes ES cell self-
renewal by maintaining repression of genes involved in lineage commitment.  
Subsequent work focusing on the chromatin state of ES cells found a large 
number of these PRC2 bound genes have distal-regulatory elements, referred to as 
“poised enhancers”, that in addition to H3K27me3, also display high levels of mono- and 
di- H3K4 methylation (presumably catalyzed by the mammalian homologue of trx) (Calo 
and Wysocka, 2013; Heintzman et al., 2007; Rada-Iglesias et al., 2011). Consistent with 
the proposed role of PRC2 bound genes during lineage commitment and differentiation, 
these poised enhancers are sufficient to drive cell-type and stage-specific gene 
expression in the developing embryo (Rada-Iglesias et al., 2011). Following the 
identification of poised enhancers in ES cells, a similar chromatin signature was 
identified on numerous distal-regulatory elements in NSCs (Amador-Arjona et al., 2015; 
Bergsland et al., 2011; Mateo et al., 2015). Functional studies indicate that the 
vertebrate homologue of trx, mixed-lineage leukemia 1 (Mll1), is required in adult NSCs 
in the subventricular zone of mice to maintain the proneural gene Dlx2 in a poised state 
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for subsequent activation in their progeny (Lim et al., 2009). Thus, maintenance of a 
poised chromatin state by PcG and TrxG genes may be a universal mechanism to 
prime the genome of stem cells for subsequent differentiation. In agreement with the 
red-light/green-light model of PcG/TrxG gene regulation, PcG proteins are thought to 
maintain repression of poised enhancer in stem cells, while TrxG proteins maintain 
these regions of the genome for subsequent activation during lineage commitment 
(Heinz et al., 2010).  
Regulation of the transition from a poised to active chromatin state.  
The finding that lineage-commitment and differentiation genes are maintained in a 
poised chromatin state in stem cells strongly suggests that proper regulation of the 
poised enhancers is likely important to balance self-renewal and differentiation. 
Elucidating how the poised chromatin state is maintained during stem cell self-renewal, 
and how the transition from a poised to active state is regulated in stem cell progeny will 
likely have a broad impact on our understanding of stem cell biology.   
In contrast to poised enhancers, enhancers associated with active genes 
frequently display high levels of acetylated lysine 27 on histone 3 (H3K27ac), whereas 
H3K27me3 is absent (Creyghton et al., 2010). Furthermore, when ES cells are induced 
to differentiated into neuroectoderm, enhancers of developmental regulators of 
neurogenesis, which display a poised chromatin signature (H3K4me1+, H3K27me3+, 
H3K27ac-) in ES cells, transition to an activate chromatin state (H3K4me1+, 
H3K27me3-, H3K27ac+) (Rada-Iglesias et al., 2011). In contrast, distal-regulatory 
elements associated with genes involved in mesoderm or endoderm lineage 
commitment maintain their poised chromatin signature during neuroectoderm 
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differentiation (Rada-Iglesias et al., 2011). This indicates the transition from methylation 
to acetylation of H3K27 is involved in the activation of poised enhancers, and likely 
drives expression of the pro-differentiation genes they regulate. In addition, this 
suggests stem cell multipotency is dependent on maintaining the enhancers of genes 
that control the lineage commitment or differentiation of their progeny in a poised 
chromatin state, and that production of a specific lineage or differentiated cell type 
involves precise activation of a subset of these poised enhancers. 
How is the transition from a poised to active chromatin state regulated? 
Numerous components of the transcription factor networks that maintain ES cell and 
tissue specific stem cell identity bind to poised enhancers, and likely contribute to their 
regulation (Amador-Arjona et al., 2015; Bergsland et al., 2011; Creyghton et al., 2010; 
Heinz et al., 2015; Mateo et al., 2015; Rada-Iglesias et al., 2011). In the blood, 
components of the hematopoietic stem cell (HSC) transcription factor network maintain 
distinct subsets of H3K4me1+ enhancers in differentiated macrophages and B-cells 
through cooperative binding with lineage-specific transcription factors (Heinz et al., 
2010). Maintenance of these H3K4me1+ enhancers facilitates subsequent binding and 
activation by signal dependent transcription factors (Heinz et al., 2010; Heinz et al., 
2015). This provides a compelling model to explain how cell-type specific enhancers are 
regulated, however, these studies did not examine H3K27me3 or H3K27ac, and so the 
relevance of this model to poised enhancers specifically remains to be tested. In neural 
stem cells (NSCs) the H3K27 specific demethylase JMJD3 is required for robust 
activation of the poised gene Dlx2 in the progeny of adult NSCs (Park et al., 2014). 
However, JMJD3 is expressed in both NSCs and their progeny, and how the activity of 
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JMJD3 is coordination on the Dlx2 locus remains unclear. Thus, continued investigation 
is necessary to elucidate how transcription factor networks interact with chromatin 
modifying enzymes to maintain the poised state of enhancers in stem cells, and 
coordinate the transition of these enhancers to an active state in stem cell progeny. 
The link between stem cell biology and the formation of cancer.  
Tissue specific stem cells divide asymmetrically to regenerate while producing 
intermediate progenitors, also called transit-amplifying cells, which function to amplify 
the output of each stem cell division. As opposed to their parental stem cells, 
intermediate progenitors, have a restricted developmental and proliferative potential, 
limiting their number of divisions and the differentiated cell types they can produce. For 
example, HSCs can give rise to either common lymphoid progenitors, which generate 
differentiated granulocytes and macrophages, or common myeloid progenitors, which 
give rise to differentiated B-cells, T-cells and natural killer cells (Chotinantakul and 
Leeanansaksiri, 2012). To meet the rapid pace of development and the fluctuating 
demands of adult tissues, intermediate progenitors need to rapidly commit to their 
restricted identity before entering the cell cycle within hours of their birth (Homem et al., 
2013; Ponti et al., 2013). Precise specification of intermediate progenitor identity likely 
involves restriction of stem cell self-renewal pathways, and upregulation of intermediate 
progenitor specific programs. Mechanistic insight into this critical transition will have 
broad clinical applications.  
Genetically engineered mouse models have revealed mutations commonly found 
in human tumors lead to oncogenic transformation when induced in stem cells or 
specific intermediate progenitor populations, but not their differentiated progeny 
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(Lamprecht and Fich, 2015; Liu et al., 2011; Liu and Zong, 2012; Zong et al., 2015). 
Also, human cancer cells that phenotypically resemble intermediate progenitors 
occasionally acquire the capacity to aberrantly revert to a less restricted stem cell-like 
identity. This inter-conversion between stem cells and intermediate progenitors may be 
a primary mechanism driving tumor expansion (Magee et al., 2012). Because of their 
unique susceptibility to oncogenic lesions that impair differentiation, intermediate 
progenitors are suspected to act as the cell-of-origin for numerous tumor types 
(Lamprecht and Fich, 2015; Zong et al., 2015). Thus understanding how the restricted 
identity of intermediate progenitors is established and maintained to ensure their 
subsequent differentiation will likely inform clinical efforts to combat cancer.  
 Interestingly, both gain- and loss-of-function mutations in PcG and TrxG proteins 
have been identified in distinct tumor types, and the molecular mechanisms by which 
these lesions contribute to tumor growth are just beginning to be elucidated (Herz et al., 
2014; Piunti and Shilatifard, 2016; Sauvageau and Sauvageau, 2010; Slany, 2016). 
One attractive possibility is that context dependent mis-regulation of poised 
differentiation genes may contribute to the tumor-suppressive versus oncogenic effects 
of PcG and TrxG mutations in different tissues. While this model is gaining traction 
(Herz et al., 2014), further investigation is necessary to conclusively demonstrate the 
link between the tumorigenic effects of PcG and TrxG mutations and mis-regulation of 
poised differentiation genes.  
Drosophila neuroblasts as a model of stem cell biology 
Due to their fast generation time, amenability to genetic manipulation and their similar 
physiology to more complex metazoans, the fruit fly Drosophila has served as a work 
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horse to identity molecular mechanisms controlling many aspects of biology. The 
Drosophila nervous system is produced by neural stem cells (neuroblasts) that 
delaminate from the neural epithelium in the early embryo, perform the bulk of 
neurogenesis during the larval stages, and then terminally differentiate or die shortly 
after pupation (Doe, 2008; Homem et al., 2014; Maurange et al., 2008). The neuroblasts 
that populate the larval central brain can be broadly categorized into two classes, 
referred to as type I and type II neuroblasts, based on molecular marker expression, 
and their unique lineage hierarchies (Bello et al., 2008; Boone and Doe, 2008; Weng 
and Lee, 2011). Each larval brain lobe contains close to 100 type I neuroblasts that 
undergo repeated rounds of asymmetric division to self-renew while generating ganglion 
mother cells (GMCs). Shortly after their birth, these GMCs undergo a single 
differentiating division to produce two neurons (Homem et al., 2013).  In comparison, 
each larval brain lobe contains only 8 type II neuroblasts which also invariably divide 
asymmetrically, but amplify the number and diversity of progeny produced by each 
division through generating intermediate neural progenitors (INPs) (Bello et al., 2008; 
Boone and Doe, 2008). Similar to vertebrate intermediate progenitors, INPs possess a 
restricted developmental and proliferative potential, and undergo 5-6 rounds of 
asymmetric division to produce GMCs before terminally differentiating (Bayraktar et al., 
2010; Bayraktar and Doe, 2013). The GMCs produced by type II neuroblast lineages 
also undergo a single differentiating division, but can give rise to either terminally 
differentiated neurons or glia (Viktorin et al., 2011). Their similar physiology to 
mammalian tissue-specific stem cells makes Drosophila neuroblasts an excellent model 
to identity conserved mechanisms controlling stem cell self-renewal, intermediate 
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progenitor commitment, and the terminal differentiation of their progeny (Doe, 2008; 
Homem and Knoblich, 2012; Janssens and Lee, 2014).  
The transcription factor networks controlling neuroblast identity 
Genetic investigation of neuroblast regulation has revealed their self-renewal is 
controlled by a highly conserved transcription factor network. The Notch signaling 
pathway regulates many aspects of stem cell biology in both Drosophila and vertebrates 
(Liu et al., 2010; Pierfelice et al., 2011), and is a critical input into the neuroblast self-
renewal transcription factor network. Notch encodes a transmembrane protein that upon 
extra-cellular ligand binding undergoes proteolytic activation, releasing the Notch intra-
cellular domain (NICD). The NICD then translocates to the nucleus where it complexes 
with the DNA binding protein Suppressor of Hairless (Su(H)) to activate target gene 
expression (Hori et al., 2013; Liu et al., 2010).  
In neuroblasts the NICD/Su(H) complex directly regulates activation of the self-
renewal transcription factors Enhancer of split-m (E(spl)m), deadpan (dpn), klumpfuss 
(klu), and the O-isoform of grainyhead (grhO) (San-Juán and Baonza, 2011; Xiao et al., 
2012; Zacharioudaki et al., 2015; Zacharioudaki et al., 2012). The basic-helix-loop-helix-
orange transcription factors E(spl)m and Dpn are Drosophila homologues of the HES 
family of transcription factors, which also regulate vertebrate neural stem cell identity 
(Imayoshi and Kageyama, 2014). E(spl)m and Dpn bind DNA as either homo- or 
hetero-dimers that are all thought to recognize a similar consensus motif (Zacharioudaki 
et al., 2012). Whereas mutation of either the E(spl) locus or dpn alone does not lead to 
neuroblast loss, simultaneous mutation of the E(spl) locus and dpn together results in 
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the rapid premature differentiation of neuroblasts (Zacharioudaki et al., 2012). This 
indicates E(spl)m and Dpn act redundantly to promote neuroblast self-renewal, 
suggesting they likely regulate common target genes. The EGR-like transcription factor 
KIu is homologous to mammalian Wilms Tumor-1 (Pei and Grishin, 2015), and in 
contrast to E(spl) or dpn, the single mutation of klu results in premature neuroblast 
differentiation (Berger et al., 2012; Xiao et al., 2012). Thus, Klu function is required for 
neuroblast self-renewal. Lastly, GrhO is a member of the Grh family of transcription 
factors, which has expanded in mammals and includes Grh-like 1,2 & 3 (Wang and 
Samakovlis, 2012).  The single grh locus in Drosophila encodes multiple isoforms which 
all share a common DNA binging domain coupled to different trans-regulatory domains. 
GrhO is the sole isoform expressed in central brain neuroblasts, and is thought to act 
primarily as a transcriptional activator (Almeida and Bray, 2005). Indeed, GrhO has 
been included in models of the neuroblast self-renewal transcription factor network 
(Berger et al., 2012). However, the role of GrhO during maintenance of neuroblast 
identity remains unclear. Mutation of grhO results in mild neuroblast cell cycle defects, 
but does not lead to overt premature differentiation (Cenci and Gould, 2005). One 
possible explanation is that, like E(spl)m and Dpn, GrhO may act in a partially 
redundant manner with other neuroblast transcriptional activators, masking the role of 
GrhO during the regulation of neuroblast self-renewal.  
In addition to the core neuroblast transcription factor network, type II neuroblasts 
also uniquely express the P1-isoform of the ETS-1 transcription factor pointed (pntP1), 
members of the SP1/KLF family of transcription factors including buttonhead (btd) and 
Sp1, as well as the homeodomain transcription factor Distal-less (Dll) (Carney et al., 
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2012; Yang et al., 2015). Thus, PntP1, Btd, Sp1, and Dll constitute a type II neuroblast 
specific transcription factor network. During delamination from the optic placode 
neuroepithelium in the Drosophila embryo, the EGFR signaling pathway is necessary 
for activation of pntP1 and establishment of a type II neuroblast identity (Hwang and 
Rulifson, 2011). However, EGFR signaling is dispensable for maintenance of a type II 
neuroblast identity and PntP1 expression in the larval brain (unpublished data). An 
attractive model to explain the temporal specific requirement of EGFR signaling is that 
the type II neuroblast-specific transcription factor network is self-propagating, and may 
include auto-regulatory and feedforward loops to maintains its own activity. Consistent 
with this possibility, mutation of btd results in reduction or loss of PntP1 expression in 
type II neuroblasts (Xie et al., 2014), and Btd and Sp1 have been show to directly 
activate Dll during Drosophila leg development (Estella and Mann, 2010). In addition, 
Mis-expression of pntP1 or btd alone confers a type II neuroblast-like identity to type I 
neuroblasts, causing them to directly produce INP-like progeny rather than GMCs 
(Komori et al., 2014a; Xie et al., 2014; Zhu et al.,  2011). This suggests expression of 
either pntP1 or btd is sufficient to jump start the type II neuroblast specific transcriptional 
program, potentially by initiating a feedforward mechanism. However, additional 
experiments are necessary to test whether direct cross-talk between PntP1, Btd, Sp1, 
and Dll exists in type II neuroblasts.  
Initiation of intermediate neural progenitor commitment in type II neuroblast 
lineages 
Following their birth, INPs undergo a maturation phase lasting approximately 6-8 hours, 
during which their developmental potential becomes stably restricted prior to entry into 
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Figure 3: The asymmetrically 
segregated fate-determinants Brat 
and Numb initiate INP commitment 
by downregulating self-renewal 
transcription factors.  
the cell cycle (Bowman et al., 2008; Homem et al., 2013; Weng et al., 2010). 
Importantly, immature INPs can be unambiguously identified based on proximity to their 
parental type II neuroblast and expression of a well characterized set of molecular 
markers. Thus, INP maturation provides an exceptional model to identify fundamental 
mechanisms that restrict the identity of 
intermediate progenitors following asymmetric 
stem cell division (Janssens and Lee, 2014). 
Genetic investigation has revealed that INP 
commitment is initiated by the asymmetrically 
segregated fate-determinants Brain-tumor 
(Brat) and Numb (Betschinger et al., 2006; 
Bowman et al., 2008; Lee et al., 2006a; Lee et 
al., 2006c). Brat and Numb are both expressed 
in type II neuroblasts and localize to the cell 
membrane where they are thought to be held in an inactive confirmation. During type II 
neuroblast mitosis, Brat and Numb become segregated to the basal membrane 
resulting in their exclusive inheritance by the newly born immature INP following 
asymmetric division (Figure 3). Brat and Numb initiate INP commitment by transiently 
down-regulating expression of the self-renewal transcription factors Notch, 
E(spl)m,Dpn, and Klu during INP maturation (Figure 3) (Haenfler et al., 2012; 
Janssens et al., 2014; Janssens and Lee, 2014; Xiao et al., 2012).  The Brat protein 
functions as a translational repressor of specific mRNA targets, and has been shown to 
directly bind dpn and klu mRNA in the Drosophila embryo (Loedige et al., 2015). Numb 
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is a classic inhibitor of Notch signaling and is thought to promote endocytosis of the 
Notch receptor, removing it from the membrane and preventing activation (Couturier et 
al., 2012 ; Giebel and Wodarz, 2012). When either brat or numb are mutated, INP 
commitment fails, resulting in their rapidly reversion to a type II neuroblast identity and 
the formation of massive numbers of supernumerary neuroblasts (Bowman et al., 2008; 
Xiao et al., 2012). Similarly, mis-expression of Notch, E(spl)m, Dpn, or Klu during the 
early, but not late stages of INP maturation can prevent INP commitment and drive 
efficient reversion to a type II neuroblast identity (Janssens et al., 2014; Xiao et al., 
2012). In addition, mutation of either dpn or klu can completely suppress the formation 
of supernumerary neuroblasts in brat mutants (Janssens et al., 2014; Xiao et al., 2012). 
This strongly suggests the transcription factors Notch, E(spl)m, Dpn, and Klu promote 
type II neuroblst self-renewal by preventing premature INP commitment, and must be 
transiently downregulated to initiate the restriction of INP developmental potential. 
However, Notch, E(spl)m, Dpn, and Klu all become re-expressed in the INP upon 
completion of maturation, suggesting the competency of INPs to respond to these self-
renewal factors is restricted.  
Maintenance of the restricted developmental potential of intermediate neural 
progenitors 
The C2H2 zinc finger transcription factor Earmuff (Erm) is specifically expressed in 
immature INPs, and functions as the master regulator of INP commitment (Janssens et 
al., 2014). Type II neuroblasts mis-expressing Erm prematurely differentiate; whereas 
erm null INPs spontaneously revert into supernumerary type II neuroblasts (Weng et al., 
2010). Erm restricts the developmental potential of INPs by functioning primarily as a 
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transcriptional repressor and restricts the competency of INPs to respond to reactivation 
of Notch, E(spl)m, Dpn, and Klu (Janssens et al., 2014). Erm is the Drosophila 
homologue of mammalian Fezf1 and Fezf2 which also regulate numerous cell-fate 
decisions in the mammalian brain (Eckler and Chen, 2014). The molecular mechanism 
by which Erm, Fezf1 and Fezf2 regulate target gene transcription is likely conserved 
because these transcription factors all recognize the consensus binding motif 
AAAAGAGCAAC in vitro (Janssens et al., 2016) (see Chapter 3), and overexpression of 
Fezf1 or Fezf2 in immature INPs completely rescues the supernumerary type II 
neuroblast phenotype in erm null brains (Weng et al., 2010). Thus, understanding the 
mechanism by which Erm restricts the developmental potential of INPs will likely provide 
critical insight into the regulation of cell-fate commitment in the mammalian brain.   
Maintaining earmuff in a poised chromatin state in type II neuroblasts balances 
continual self-renewal with rapid restriction of developmental potential following 
asymmetric division.  
Similar to vertebrate stem cells, PcG and TrxG genes are important regulators of type II 
neuroblast lineages. Trx is required to maintain pntP1 and btd expression in type II 
neuroblasts, and for activation of erm expression in immature INPs (Komori et al., 
2014a). When trx is mutated type II neuroblasts adopt a type I neuroblast-like identity, 
and directly giving rise to GMCs rather than INPs (Komori et al., 2014a). The 
endogenous erm promoter and immature INP enhancer are maintained in a poised 
state in type II neuroblasts and display high levels of H3K4me2, and H3K27me3 and 
low levels of H3K27ac (Figure 4) (Janssens et al., 2016) (see Chapter 3). This facilitates 
rapid activation of Erm expression in immature INPs within two-hours of their birth 
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(Janssens et al., 2016) (see Chapter 3). However, in contrast to the aforementioned 
red-light/green-light model of PcG/TrxG gene regulation, mutation of critical components 
of PRC2 does not result in premature activation of Erm expression in type II 
neuroblasts, and instead causes a reduction in Erm expression in immature INPs 
(Janssens et al., 2016) (see Chapter 3). Thus, PRC2 is not required to maintain 
repression of erm in type II neuroblasts. Consistent with this interpretation, a transgenic 
reporter containing the erm immature INP enhancer displays high levels of H3K4me2, 
but low or undetectable levels of H3K27me3 in type II neuroblasts, yet it remains 
inactive in type II neuroblasts (Janssens et al., 2016) (see Chapter 3). Interestingly, in 
direct contrast to PRC2, reducing the activity of the histone deacetylase HDAC1/Rpd3 
results in premature activation of the erm immature INP enhancer in type II neuroblasts, 
and causes them to prematurely differentiate (Janssens et al., 2016) (see Chapter 3). 
Thus, HDAC1/Rpd3, not PRC2, is required to maintain the repression of erm in type II 
neuroblasts.  
How is the transition from a poised to active chromatin state regulated in 
immature INPs? The core self-renewal transcription factors E(spl)m, Dpn, and Klu all 
directly bind the erm immature INP enhancer and maintain its repression in type II 
neuroblasts through HDAC1/Rpd3 (Figure 4) (Janssens et al., 2016) (see Chapter 3).  
The type II neuroblast-specific transcription factor PntP1 also directly binds the erm 
immature INP enhancer, priming it for activation in immature INPs (Janssens et al., 
2016) (see Chapter 3). In addition, Btd, Sp1 and Dll also likely bind the erm immature 
INP enhancer, potentially cooperating with PntP1 to recruit a histone acetyltransferase 
(Figure 4), but this remains to be tested (unpublished data). Following asymmetric type 
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Figure 4: Maintenance of the erm locus in a poised chromatin state in type II 
neuroblasts, and the transition to an active state in their immature INP progeny  
II neuroblast division, selective down-regulation of Klu, Dpn and E(spl)m function in 
immature INPs  alleviates Rpd3 mediated repression of the poised erm enhancer. This 
provides a permissive cue to allow accumulation of H3K27ac and rapid activation of 
Erm expression (Figure 4). Regulation of the erm immature INP enhancer offers a novel 
paradigm to explain the transition from a poised to active chromatin state, in which 
removing a group of transcriptional repressor proteins, rather than addition of an 
activator, controls the precise timing of poised enhancer activation in stem cell progeny 
(Figure 4).  
Erm is the first example of a poised gene that is required to restrict the 
developmental potential of intermediate progenitors and prevent them from reverting to 
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aberrantly reacquire a stem cell identity. Once activated, Erm functions as part of a 
negative feedback circuit, directly binding the promoter of its activator pntP1 as well as 
the promoter of grhO and repressing their expression in INPs (Janssens et al., 2016) 
(see Chapter 3). This is consistent with the model that intermediate progenitor 
commitment requires downregulation of stem cell self-renewal pathways. However, 
while co-overexpression of PntP1 and GrhO together can enhancer the formation of 
supernumerary type II neuroblasts in an erm hypomorphic mutant background, 
overexpression of PntP1 and GrhO in a wild-type background does not produce 
supernumerary neuroblasts (Janssens et al., 2016) (see Chapter 3). Thus, Erm likely 
down-regulates additional transcriptional activators that function cooperatively with 
PntP1 and GrhO to promote type II neuroblast self-renewal.  This strongly suggests that 
rapidly activating poised genes directly repress components of the stem cell 
transcription factor network to ensure stable commitment to a lineage-restricted or 
differentiated cell-fate in stem cell progeny.  
Outlook 
Realizing the therapeutic potential of stem cell biology requires an in-depth 
understanding of the molecular mechanisms controlling their self-renewal as well as the 
generation of specific differentiated progeny. Extensive investigation of both ES cells 
and tissue specific stem cells has revealed intricate transcription factor networks 
balance self-renewal with the capacity to generate more restricted cell types (Figure 1). 
While distinct stem cell populations are regulated by unique, sometimes partially 
overlapping collections of transcription factors, common themes underlying their control 
of self-renewal and differentiation have emerged. In addition to their auto-regulatory and 
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feedforward targets, these transcription factors also directly regulate genes that promote 
lineage commitment or differentiation of stem cell progeny. This group of pro-
differentiation targets is often maintained in a poised chromatin state by the PcG and 
TrxG proteins. But how transcription factor networks maintain the poised chromatin 
state during stem cell self-renewal, and coordinate the transition to an active state in 
their differentiating progeny remains unclear. Studies of Drosophila type II neuroblasts 
suggest the transition from a poised to active chromatin state is likely regulated by 
selective downregulation of repressive components of the stem cell transcription factor 
network to alleviate HDAC1/Rpd3 mediated repression of these poised enhancers 
(Figure 3 and 4). Once activated, these poised genes likely facilitate lineage-
commitment or differentiation by forming a negative feedback circuit, and directly 
repressing components of the stem cell transcription factor network. Continued 
investigation of type II neuroblast regulation will likely continue to break new ground in 
our understanding of poised enhancer regulation and the fundamental mechanisms 
balancing stem cell self-renewal and differentiation.  
 The identification of similar poised regulatory circuits in other stem cell lineages 
will depend on several key advances including: (1) identification of stem cell specific 
poised genes that are upregulated in their immediate progeny, (2) identification of the 
functional consequences of stem cell transcription factor binding to poised enhancers 
(i.e activation versus repression), and (3) identification of the mechanisms that alter the 
activity of stem cell transcription factor networks in the differentiating progeny. Several 
steps towards realizing this goal in vertebrate stem cells are already in place. For 
example, during asymmetric division, mammalian NSCs have been shown to 
25 
    
asymmetrically segregate Staufen2 into their progeny, as well as cargo mRNAs 
encoding the mammalian homologue of Brat, called Trim32, and another RNA binding 
protein called Pumilio-2 (Kusek et al., 2012; Vessey et al., 2012). This mechanism in 
important to promote lineage progression and differentiation, but the direct targets of 
Trim32 and Pumilio-2 in the progeny of vertebrate NSCs have yet to be identified. In 
addition, the vertebrate homologue of Erm, Fezf2, is bound by PRC2 in both human and 
mouse ES cells, and the FezF2 434 neurogenic enhancer displays chromatin marks 
indicative of a poised state (Boyer et al., 2006; Eckler et al., 2014; Rada-Iglesias et al., 
2011; Shim et al., 2012). This suggests critical aspects of the relay circuit controlling 
INP commitment in type II neuroblast lineages are likely conserved, and may regulate 
cell-fate decisions in the mammalian brain. Ultimately, elucidating mammalian poised 
regulatory circuits will inform clinical efforts to direct stem cells to differentiate into 
specific cell types for regenerative medicine. Understanding these poised relay circuits 
will also likely provide insight into the context dependent mechanisms by which 
oncogenic lesions, such as mutations of PcG and TrxG genes, contribute to stem cell 
and intermediate progenitor cell derived tumors.  
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Chapter 2: dFezf/Earmuff restricts progenitor cell potential by 
attenuating the competence to respond to self-renewal 
factors 
Abstract 
Despite expressing stem cell self-renewal factors, intermediate progenitor cells possess 
restricted developmental potential, which allows them to give rise to exclusively 
differentiated progeny rather than stem cell progeny. Failure to restrict the 
developmental potential can allow intermediate progenitor cells to revert into aberrant 
stem cells that might contribute to tumorigenesis. Insight into stable restriction of the 
developmental potential in intermediate progenitor cells could improve our 
understanding of the development and growth of tumors, but the mechanisms remain 
largely unknown. Intermediate neural progenitors (INPs) generated by type II neural 
stem cells (neuroblasts) in fly larval brains provide an in vivo model for investigating the 
mechanisms that stably restrict the developmental potential of intermediate progenitor 
cells. Here, we report that the transcriptional repressor protein Earmuff (Erm) functions 
temporally after Brain tumor (Brat) and Numb to restrict the developmental potential of 
uncommitted (immature) INPs. Consistently, endogenous Erm is detected in immature 
INPs but undetectable in INPs. Erm-dependent restriction of the developmental 
potential in immature INPs leads to attenuated competence to respond to all known 
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neuroblast self-renewal factors in INPs. We also identified that the BAF chromatin-
remodeling complex likely functions cooperatively with Erm to restrict the developmental 
potential of immature INPs. Together, these data led us to conclude that the Erm-BAF-
dependent mechanism stably restricts the developmental potential of immature INPs by 
attenuating their genomic responses to stem cell self-renewal factors. We propose that 
restriction of developmental potential by the Erm-BAF-dependent mechanism 
functionally distinguishes intermediate progenitor cells from stem cells, ensuring the 
generation of differentiated cells and preventing the formation of progenitor cell-derived 
tumor initiating stem cells 
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Introduction 
Tissue-specific stem cells often generate differentiated cell types indirectly through 
intermediate progenitor cells during normal development and the maintenance of 
homeostasis (Chang et al., 2012; Franco and Müller, 2013; Homem and Knoblich, 2012; 
Lui et al., 2011; Ming and Song, 2011; Weng and Lee, 2011). Intermediate progenitor 
cells possess restricted developmental potential, which allows them to give rise to 
exclusively differentiated progeny, thereby amplifying the output of stem cells. 
Accumulating evidence suggests that the acquisition of aberrant stem cell properties by 
intermediate progenitor cells might be an underlying mechanism that leads to the 
initiation of tumorigenesis (Haenfler et al., 2012; Komori et al., 2014b; Liu et al., 2011; 
Schwitalla et al., 2013; Weng et al., 2010; Xiao et al., 2012). Thus, understanding the 
mechanisms that restrict the developmental potential of intermediate progenitor cells 
might lead to the discovery of novel strategies to attenuate tumor growth. 
The type II neuroblast lineage in the fly larval brain provides an excellent genetic 
model to investigate the mechanisms that restrict the developmental potential of 
intermediate progenitor cells in vivo (Bello et al., 2008; Boone and Doe, 2008; Bowman 
et al., 2008; Komori et al., 2014b; Weng et al., 2010; Xiao et al., 2012). A type II 
neuroblast can be unambiguously identified by the expression of Deadpan (Dpn+) and 
lack of Asense (Ase-), and divides asymmetrically to self-renew and to generate a newly 
born immature INP (Figure 6A). While the expression of self-renewal factors is 
maintained in the type II neuroblast, their expression becomes rapidly extinguished in 
the newly born immature INP (Xiao et al., 2012). This newly born INP undergoes a 
stereotypical maturation process during which its developmental potential becomes 
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stably restricted and the expression of Ase is activated. Upon completing maturation, an 
INP divides only five to six times to generate exclusively differentiated progeny despite 
reactivating the expression of all known neuroblast self-renewal factors. Thus, it is likely 
that the restriction of developmental potential during the maturation of an immature 
INPs results in attenuated competence to respond to the neuroblast self-renewal factors 
in an INP, but the mechanisms are not understood.  
The neuroblast self-renewal factors include Dpn, Klumpfuss (Klu), Enhancer of 
split m (E(spl)m) and Notch (San-Juán and Baonza, 2011; Weng et al., 2010; Xiao et 
al., 2012; Zacharioudaki et al., 2012; Zhu et al., 2012). Removal of Notch function alone 
or dpn and E(spl)m function simultaneously leads to premature neuroblast 
differentiation whereas over-expression of any of the neuroblast self-renewal factors in 
type II neuroblasts leads to massive formation of supernumerary neuroblasts. 
Unexpectedly, while over-expression of klu in Ase- immature INPs driven by the Erm-
Gal4(II) driver induces a robust supernumerary neuroblast phenotype, over-expression 
of klu in Ase+ immature INPs driven by the Erm-Gal4(III) failed to induce supernumerary 
neuroblast formation (Xiao et al., 2012). The expression level of Erm-Gal4(III) is 
approximately 50% of Erm-Gal(II) (Janssens and Lee, unpublished observation). 
However, over-expression of two copies of the UAS-klu transgenes driven by two 
copies of the Erm-Gal4(III) driver was not sufficient to induce a supernumerary 
neuroblast phenotype remotely comparable to over-expression of one copy of the UAS-
klu transgene driven by one copy of the Erm-Gal4(II) driver (Xiao et al., 2012). Although 
we cannot quantitatively control the exact expression level of the UAS-klu transgenes 
driven by Erm-Gal4(II) versus Erm-Gal4(III) in these experiments, these results suggest 
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that Ase+ immature INPs are significantly less responsive to the expression of 
neuroblast self-renewal factors than Ase- immature INPs. Understanding the 
mechanisms that alter the responsiveness to neuroblast self-renewal factors in Ase+ 
immature INPs will provide critical insight into the restriction of developmental potential.  
The transcription factor Erm functionally distinguishes an INP from a neuroblast 
(Weng et al., 2010). Erm encodes an evolutionarily conserved C2H2 zinc-finger 
transcription factor, and the vertebrate orthologs of Erm can activate or repress gene 
expression in a context dependent manner (Hirata et al., 2006; Weng et al., 2010; Yang 
et al., 2012). Erm is dispensable for the formation of INPs, but INPs in erm null brains 
spontaneously revert into supernumerary type II neuroblasts. Importantly, restoring erm 
function by over-expressing erm or the vertebrate ortholog of erm (fez or fezl) rescued 
the supernumerary neuroblast phenotype, strongly suggesting that the function of Erm 
is evolutionarily conserved. Erm suppresses the reversion of INPs by antagonizing 
Notch signaling (Weng et al., 2010). However, the mechanisms by which Erm restricts 
the functional output of Notch signaling in INPs are completely unknown. In addition, 
understanding if Erm might exert a similar regulatory effect on other neuroblast self-
renewal factors will provide critical insight into the mechanisms that functionally 
distinguish an INP from a neuroblast.  
In this study, we show that Erm functions as a transcriptional repressor to stably 
restrict their developmental potential in immature INPs. Erm functions temporally after 
Brat and Numb in immature INPs to suppress the formation of supernumerary 
neuroblasts, and endogenous Erm protein is exclusively expressed in immature INPs. 
Erm-dependent restriction of the developmental potential in immature INPs leads to 
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attenuated competence to respond to all known neuroblast self-renewal factors in INPs. 
Thus, the Erm-dependent mechanism stably and globally restricts the genomic 
response to neuroblast self-renewal factors. We identified that the BAP chromatin-
remodeling complex also functions temporally after Brat and Numb to restrict the 
developmental potential of immature INPs. Importantly, over-expression of a dominant 
negative form of Brm strongly enhanced the supernumerary neuroblast phenotype in 
erm hypomorphic brains. Thus, we propose that Erm and the BAP complex function 
cooperatively to stably restrict the developmental potential of immature INPs and to 
functionally distinguish an INP from a neuroblast. 
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Results 
Erm functions in immature INPs to suppress the formation of supernumerary type 
II neuroblasts 
We hypothesized that restriction of the developmental potential in immature INPs alters 
the responsiveness to neuroblast self-renewal factors, preventing INPs from aberrantly 
reverting into supernumerary neuroblasts in response to the re-activation of neuroblast 
self-renewal factors. We used the bratDG19310/11 hypomorphic genetic background to 
investigate the mechanisms that restrict the developmental potential of immature INPs 
(Komori et al., 2014b; Xiao et al., 2012). Briefly, Brat prevents the formation of 
supernumerary neuroblasts by acting at two temporally distinct stages during maturation 
(Figure 6A). First, Brat prevents a newly born immature INP, which lacks the expression 
of both Erm-Gal4(II) and Ase (Figure 6A, 5D), from reverting into a supernumerary 
neuroblast by rapidly extinguishing the function of neuroblast self-renewal factors. 
Newly born immature INPs mutant for brat rapidly revert into supernumerary 
neuroblasts instead of progressing through maturation, and removing the function of the 
neuroblast self-renewal gene klu or dpn suppressed the supernumerary neuroblast 
phenotype (Figure 5 A-C) (Xiao et al., 2012). Second, Brat continues to play an 
important role in the Ase- immature INP, which shows the expression of Erm-Gal4(II) 
(Figure 6A), to promote the maturation of immature INPs. We confirmed that the 
temporal expression pattern of Erm-Gal4(II) and Erm-Gal4(III) is not altered in 
bratDG19310/11 brains (Figure 5D-G). Restoring brat function in Ase- immature INPs 
suppressed the supernumerary neuroblast phenotype in bratDG19310/11 brains while  
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Figure 5: Brat functions in the newly born immature INP or Ase- immature INP to 
suppress the formation of supernumerary neuroblasts. (legend continued on next page)
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Figure 5 (continued): (A-C) Removal of dpn function suppressed the supernumerary neuroblast 
phenotype in brat null brains. (C) The quantification of supernumerary neuroblasts in wild-type or 
dpn mutant type II neuroblast clones in brat null brains. (D-G) The expression pattern of Erm-
Gal4(II) and Erm-Gal4(III) appeared indistinguishable between wild-type and brat hypomorphic 
brains. wild-type or bratDG19310/11 larvae carrying the UAS-mCD8-GFP, hs-flp, Act-FRT-FRT-lacZ, 
Erm-Gal4 (II) or Erm-Gal4(III) transgenes were genotyped at hatching, and heat-shocked at 37oC 
for 90 minutes at 24 hours after hatching to induce the lineage clones. Larvae were dissected 
and processed for immunofluorescent staining at 96 hours after hatching. The specificity of Erm-
Gal4(II) or Erm-Gal4(III) expression was examined in theGal-marked lineage clones (outlined 
in yellow) derived from single type II neuroblasts in wild-type or bratDG19310/11 brains. (H-L) Over-
expression of brat in neuroblasts or in Ase- immature INPs suppressed the supernumerary 
neuroblast phenotype in brat hypomorphic brains, but over-expression of brat in Ase+ immature 
INPs had no effect. The high magnification image of the boxed area in the low magnification 
image is shown below. Scale bars, 40 m in the low magnification image and 10 m in the high 
magnification image. (L) The quantification of the average number of type II neuroblasts per 
brain lobe of the indicated genotypes.  Key: White arrow: type II neuroblast. White arrowhead: 
newly born immature INP and Ase- immature INP. Yellow arrow: Ase+ immature INP. Yellow 
arrowhead: INP. The dotted yellow line separates the brain from the optic lobe (OL). Single 
asterisks indicate a statistically significant (p-value <0.05) difference between the marked 
genotype and the control genotype in the same bar graph as determined by the Student’s t-test. 
n.s. indicates that the difference is not statistically significant. 
restoring brat function in Ase+ immature INPs had no effects (Figure 5H-L). Thus, Brat 
functions in the newly born immature INP and the Ase- immature INP to prevent 
supernumerary neuroblast formation. 
 The unstable nature of Ase- immature INPs provides an excellent in vivo system 
to elucidate the mechanisms that restrict developmental potential during the maturation 
of immature INPs. We identified the erm gene as a genetic enhancer of brat by 
screening for haploinsufficient loci that further exacerbate the supernumerary neuroblast 
phenotype in bratDG19310/11 brains. While the heterozygosity of erm alone did not lead to 
a supernumerary neuroblast phenotype, it doubled the number of supernumerary 
neuroblasts in bratDG19310/11 brains (Figure 6B-C). To examine whether the enhancement 
of the supernumerary neuroblast phenotype in bratDG19310/11 brains by the heterozygosity 
of erm originated from Ase- or Ase+ immature INPs, we induced gal-marked lineage 
clones derived from either a single Ase+ immature INP or an INP via FRT-mediated  
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Figure 6: Erm functions in immature INPs to suppress supernumerary type II 
neuroblast formation               (legend continued on next page) 
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Figure 6 (continued): (A) A summary of the brat mutant phenotype and the expression 
patterns of the Gal4 drivers used in this study. neurob: neuroblast. Imm INP: immature INP. 
GMC: ganglion mother cell. (B-D) The heterozygosity of erm enhances the supernumerary 
neuroblast phenotype in bratDG19310/11 brains. Phalloidin (Phall) marks the cell cortex. Scale 
bars, 40 m. (D) Quantification of the average number of type II neuroblast (Dpn+Ase-) per 
brain lobe in larvae of the indicated genotypes. Error bars indicate s.d. (E) Reduction in erm 
function increases the frequency of the formation of supernumerary neuroblasts originating 
from the Ase- immature INPs or INPs. Cell identity in -Gal marked lineage clones were 
induced and analyzed following the scheme shown in Fig. S2. INP clone: a clone derived 
from a single INP. Ase+ imm INP clone: a clone derived from a single Ase+ immature INP. 
reverted clone: a clone containing supernumerary neuroblasts. The bar graphs show the 
frequency of clones observed in larval brains of the indicated genotype, and the total 
number of clones used to determine the frequency of the clones is shown in the bar graph 
for the INP clone. (F-I) Restoring erm function in the Ase- immature INPs or Ase+ immature 
INPs rescues the enhancement of the supernumerary neuroblast phenotype in bratDG19310/11 
brains induced by the heterozygosity of erm. The high magnification image of the boxed 
area in the low magnification image is shown below. Scale bars, 40 m in the low 
magnification image and 10 m in the high magnification image. (I) The quantification of the 
average number of type II neuroblasts per brain lobe of the indicated genotypes. Key for all 
figures: The dotted yellow line separates the brain from the optic lobe (OL). White arrow: 
type II neuroblast. White arrowhead: newly born immature INP and Ase- immature INP. 
Yellow arrow: Ase+ immature INP. Yellow arrowhead: INP. Single asterisks indicate a 
statistically significant (p-value <0.05) difference between the marked genotype and the 
control genotype in the same bar graph, as determined by the Student’s t-test. n.s. 
indicates that the difference is statistically insignificant. 
recombination (Figure 7A). Briefly, first instar larvae carrying a UAS-flipase transgene 
and a flip-out reporter transgene under the control of Erm-Gal4(III) and Tub-Gal80ts 
were heat-shocked at 30oC for 0-12 hours (Figure 7B). We determined that in the 
absence of heat-shocking, the leaky basal level of Erm-Gal4(III) expression was 
sufficient to induce an average of 3 clones per lobe in the control brain (Figure 7C). The 
low frequency of clone induction under this condition is ideal for analyzing the identity of 
cells in an individual clone. We only recovered Ase+ immature INP clones, which 
contain one INP per clone, GMCs and differentiated cells, and INP clones, which 
contain only differentiated cells, in control bratDG19310/+ or erm1/+ brains (Figure 6E). This 
is consistent with a wild-type INP maintaining restricted developmental potential. In 
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Figure 7: Empirical determination of the condition required for inducing a low number 
of clones derived from single Ase+ immature INPs or INPs per brain lobe. (A) The 
scheme used to induce clones derived from single Ase+ immature INPs or INPs. (B) The 
total number of cells per clone under the conditions indicated. (C) The image of a reverted 
clone derived from a single Ase+ immature INP or an INP in brat hypomorphic brains 
heterozygous for erm. (D) A three-dimensional reconstruction of a reverted clone. (E) The 
total number of clones per brain lobe induced by the basal leaky expression of Erm-Gal4(III) 
at 25oC in the genotype indicated. (F) The average number of supernumerary neuroblasts in 
the reverted clones in bratDG19310/11 brains or bratDG19310/11 brains heterozygous for erm.
bratDG19310/11 brains, more than 99% of the clones were either Ase+ immature INP clones 
or INP clones, and only 0.7% of the clones contained supernumerary neuroblasts (the 
reverted clone) (Figure 6E). This result is consistent with Brat mainly functioning in the 
newly born immature INP and the Ase- immature INP to prevent the formation of -
supernumerary neuroblasts. Importantly, 3.5% of the clones in bratDG19310/11 brains 
heterozygous for erm were the reverted clones, and these clones consistently 
possessed more supernumerary neuroblasts than the reverted clones in bratDG19310/11 
brains (Figure 6E and 7D-F). Thus, heterozygosity of erm increases the frequency that 
Ase+ immature INPs or INPs revert into neuroblasts in bratDG19310/11 brains. The 
occurrence of the reverted clones increased dramatically in erm null brains, consistent 
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with erm playing a critical role suppressing supernumerary neuroblast formation (Figure 
6E). These data strongly suggest that erm functions temporally after brat in immature 
INPs to prevent supernumerary neuroblast formation.  
 We tested whether erm indeed functions temporally after brat in immature INPs 
by restoring erm function in either Ase- or Ase+ immature INPs in bratDG19310/11 brains 
heterozygous for erm. Consistent with our hypothesis, restoring erm function in either 
Ase- or Ase+ immature INPs rescued the enhancement of the supernumerary neuroblast 
phenotype in bratDG19310/11 brains induced by the heterozygosity of erm (Figure 6F-I). 
Thus, we conclude that erm functions temporally after brat in immature INPs to 
suppress the formation of supernumerary neuroblasts. 
Erm functions temporally after Brat and Numb in immature INPs 
We assessed the expression pattern of endogenous Erm to confirm that erm indeed 
functions in Ase- and Ase+ immature INPs. We generated a transgenic fly line carrying a 
BAC clone containing the entire erm genomic locus fused in frame to a RFP epitope  
(erm-rfp). In the type II neuroblast lineage, the expression of erm-RFP was detectable in 
immature INPs located immediately adjacent to the type II neuroblast but became 
rapidly down-regulated in INPs (Figure 8A). The relative position of these Erm-
expressing immature INPs to the type II neuroblast strongly suggests that endogenous 
Erm is expressed in Ase- immature INPs. To unambiguously verify the identity of cells 
where endogenous Erm is expressed, we generated a specific antibody against the Erm 
protein. Co-immunolocalization using specific antibodies against Ase and Erm 
confirmed that endogenous Erm was absent from the newly born immature INP but 
became detectable in both Ase- and Ase+ immature INPs (Figure 8C). These data are 
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Figure 8: Erm is exclusively expressed in Ase- and Ase+ immature INPs. (A-B) The 
expression of erm-rfp is detected in immature INPs in wild-type brains but undetectable in 
brat null brains. The high magnification image of the boxed area in the low magnification 
image is shown below. Scale bars, 40 m in the low magnification image and 10 m in the 
high magnification image. (C-D) Endogenous Erm is undetectable in the newly born 
immature INP. The GFP-marked lineage clones are outlined in yellow. Scale bar, 10 m. (E-
F) Erm is undetectable in brat or numb null mutant clones. The GFP-marked lineage clones 
were outlined in yellow. Scale bar,10 m. (G) A cartoon summarizes the expression pattern 
of Erm in the type II neuroblast lineage. 
consistent with erm functioning in Ase- and Ase+ immature INPs to restrict 
developmental potential.  
We net examined the expression pattern of endogenous Erm in brat null brains to 
confirm that erm indeed functions temporally after brat in immature INPs. Indeed, the 
expression of erm-RFP was completely absent from the brat null brain, and endogenous 
Erm was undetectable in the newly born immature INP in brat null type II neuroblast 
clones (Figure 8B, D-E). Thus, these results confirm that Erm functions temporally after 
Brat in immature INPs.  
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Numb functions in parallel to Brat to prevent the formation of supernumerary 
neuroblasts (Xiao et al., 2012). A numb null type II neuroblast clone contained many 
supernumerary neuroblasts and showed an aberrant accumulation of immature INPs 
lacking Ase expression. Importantly, we never detected the expression of Erm in 
immature INPs lacking Ase expression in numb null clones, indicating that these cells 
are newly born immature INPs (Figure 8F). Thus, a numb null clone aberrantly 
accumulates newly born immature INPs. Taken together, these data indicate that Erm 
functions temporally after Brat and Numb to restrict the developmental potential of 
immature INPs.  
Erm restricts the developmental potential of immature INPs by repressing gene 
transcription 
Because the vertebrate orthologs of Erm can activate or repress gene expression in a 
context dependent manner (Hirata et al., 2006; Yang et al., 2012), we investigated 
whether Erm restricts developmental potential by activating or repressing gene 
expression. While mis-expression of wild-type Erm in neuroblasts induced premature 
differentiation of all eight type II neuroblasts in a larval brain lobe, mis-expression of 
Ermzf (containing only the zinc-fingers) had no effect (Figure 9A-B). Thus, the N-
terminus of the Erm protein is essential to confer its function in restricting developmental 
potential. We fused the Engrailed repressor domain to Ermzf converting it to act solely 
as a transcriptional repressor (ERD-Ermzf) or the VP16 transactivation domain to Ermzf 
converting it to act solely as a transcriptional activator (VP16-Ermzf) (Figure 9A). Mis-
expression of ERD-Ermzf in neuroblasts also led to premature differentiation of type II 
neuroblasts whereas mis-expression of VP16-Ermzf resulted in a mild increase in type II 
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Figure 9: Erm restricts the developmental potential in immature INPs by repressing 
gene transcription. (A) Schematics of the UAS-erm transgenes used in this series of 
experiments. ERD: engrailed repressor domain. VP16: transactivation domain. zf: zinc-
finger. (B) Over-expression of erm induces premature neuroblast differentiation by 
repressing gene transcription. Third instar larval brains of the indicated genotype were 
stained for Dpn, Ase and Phall, and the quantification of total type II neuroblasts (Dpn+Ase-) 
per brain lobe is shown. (C) Restoring erm expression rescues the supernumerary 
neuroblast phenotype in erm null brains by repressing gene transcription. Third instar larval 
brains of the indicated genotypes were stained for Dpn, Ase and Phall, and the 
quantification of total type II neuroblasts (Dpn+Ase-) per brain lobe is shown. (D) Over-
expression of VP16-ermzf exerts a dominant negative effect and further exacerbates the 
supernumerary neuroblast phenotype in erm hypomorphic brains. Third instar larval brains 
of the indicated genotypes were stained for Dpn, Ase and Phall, and the quantification of 
total type II neuroblasts (Dpn+Ase-) per brain lobe is shown. 
neuroblasts (Figure 9B). These data strongly suggest that Erm restricts developmental 
potential by acting as a transcriptional repressor. We tested this hypothesis by taking 
two complementary approaches. First, we tested whether over-expression of the erm 
transgene can rescue the supernumerary neuroblast phenotype in erm null brains. 
Restoring wild-type Erm function driven by the Erm-Gal4(III) driver rescued the 
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supernumerary neuroblast phenotype in erm null brains (Figure 9C) (Weng et al., 2010). 
Importantly, over-expression of ERD-Ermzf under the identical conditions also rescued 
the supernumerary neuroblast phenotype in erm null brains, but over-expression of 
VP16-Ermzf enhanced the supernumerary neuroblast phenotype (Figure 9C). Second, 
we tested whether over-expression of the erm transgene can rescue the supernumerary 
neuroblast phenotype in an erm hypomorphic genetic background (erm1/2; erm-flag) 
(Figure 9D). We confirmed that the temporal expression pattern of Erm-Gal4(III) is not 
altered in erm hypomorphic brains (data not shown). Consistently, over-expression of 
ERD-Ermzf driven by the Erm-Gal4(III) driver rescued the supernumerary neuroblast 
phenotype in erm hypomorphic brains, but over-expression of VP16-Ermzf enhanced the 
supernumerary neuroblast phenotype (Figure 9D). Together, these data led us to 
conclude that Erm restricts the developmental potential in immature INPs by acting as a 
transcriptional repressor, and that VP16-Ermzf can exert a dominant-negative effect on 
the restriction of developmental potential 
 We next examined which C2H2 zinc-finger elicits the function of Erm in restricting 
developmental potential. We generated the UAS-ermzf(2A) transgenes that encode Erm 
transgenic proteins containing substitutions of alanine for cysteine in individual zinc-
fingers (Figure 9A). Mis-expression of ermzf2(2A), ermzf3(2A) or ermzf4(2A) failed to induce 
premature differentiation of type II neuroblasts in wild-type brains and failed to rescue 
the supernumerary neuroblast phenotype in erm null brains (Figure 9B-C). By contrast, 
mis-expression of ermzf1(2A), ermzf5(2A) or ermzf6(2A) induced premature differentiation of 
type II neuroblasts and rescued the supernumerary neuroblast phenotype in erm null 
brains (Figure 9B-C). Thus, the zinc-finger 2-4 are essential to confer Erm function. 
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Together, we conclude that Erm restricts the developmental potential in immature INPs 
by repressing gene transcription through the zinc-finger 2-4.  
Erm-dependent restriction of the developmental potential in immature INPs leads 
to attenuated competence to respond to Klu in INPs 
To begin investigating the mechanisms by which Erm restricts the developmental 
potential of immature INPs, we examined whether over-expression of erm can 
substitute for the function of brat and suppress the supernumerary neuroblast 
phenotype in bratDG19310/11 brains. Indeed, over-expression of erm in Ase- immature 
INPs efficiently suppressed the supernumerary neuroblast phenotype in bratDG19310/11 
brains, but over-expression of erm in Ase+ immature INPs cannot (Figure 10A-C). 
These results strongly suggest that brat and erm suppress supernumerary neuroblast 
formation by regulating similar downstream mechanisms. Brat suppresses 
supernumerary neuroblast formation by antagonizing Klu (Xiao et al., 2012). Similar to 
over-expression of klu in wild-type brains, mis-expression of klu in Ase- immature INPs 
in bratDG19310/11 brains led to supernumerary neuroblast formation, but mis-expression of 
klu in Ase+ immature INPs had no effect (Figure 10D). The inefficiency in inducing 
supernumerary neuroblasts by mis-expression of klu in Ase+ immature INPs correlates 
with Erm mainly functioning in Ase+ immature INPs to restrict developmental potential. 
Thus, we hypothesized that Erm restricts developmental potential by antagonizing Klu 
function. Consistently, co-expression of erm completely suppressed supernumerary 
neuroblast formation induced by mis-expression of klu in Ase- immature INPs in wild-
type brains (Figure 10D-F). Furthermore, while mis-expression of VP16-ermzf or klu 
alone in Ase+ immature INPs did not have any effect, co-expression of VP16-ermzf and 
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Figure 10: Erm-dependent restriction of developmental potential in immature INPs 
leads to attenuated competence to respond to Klu in INPs. (A-C) Over-expression of 
erm in Ase- immature INPs can suppress the supernumerary neuroblast phenotype in brat 
hypomorphic brains. (A) The quantification of total type II neuroblasts (Dpn+Ase-) per brain 
lobe of the indicated genotypes. Scale bar, 40 m. (D-H) Co-expression of erm can 
suppress the supernumerary neuroblast phenotype induced by mis-expression of klu. (D) 
The quantification of total type II neuroblasts (Dpn+Ase-) per brain lobe of the indicated 
genotypes. Scale bar, 40 m. (I-J) Removing klu function suppresses supernumerary 
neuroblast formation in erm null brains. (I) Three-dimensional reconstructed images of the 
clones of the genotype indicated. Third instar larval brains carrying GFP-marked mosaic 
clones derived from single neuroblasts of the genotype indicated were stained for GFP, 
Dpn, Ase, Pros and Elav. Scale bar,10 m. (J) The quantification of total type II 
neuroblasts (Dpn+Ase-) per clone for the indicated genotypes.  
klu induced supernumerary neuroblast formation (Figure 10D). This result indicates the 
downstream mechanisms regulated by Erm can act cooperatively with Klu to induce 
supernumerary neuroblast formation. Finally, mis-expression of klu in Ase+ immature 
INPs also enhanced supernumerary neuroblast formation in erm hypomorphic brains 
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(Figure 10D, G-H). Together, these data strongly suggest that Erm restricts 
developmental potential by antagonizing Klu function. 
 We directly tested whether removing klu function can suppress supernumerary 
neuroblast formation in erm null brains. In erm null brains, GFP-marked mosaic clones 
derived from single type II neuroblasts contained multiple neuroblasts per clone (Figure 
10I-J). Clonally removing klu function for 72 hours was not sufficient to induce 
premature differentiation of type II neuroblasts (Berger et al., 2012; Xiao et al., 2012). 
By contrast, clonally removing klu function strongly suppressed supernumerary 
neuroblasts in erm null brains (Figure 10I-J). Thus, klu is required for supernumerary 
neuroblast formation in erm null brains. Since Klu expression is extinguished in 
immature INPs but becomes re-activated in INPs (Xiao et al., 2012), INPs are most 
likely the cells of origin for supernumerary neuroblasts in erm null brains. Thereby, Erm 
most likely restricts developmental potential by indirectly antagonizing Klu function. We 
conclude that Erm-dependent restriction of the developmental potential in immature 
INPs leads to attenuated competence to respond to Klu in INPs.  
Erm-dependent restriction of the developmental potential in immature INPs leads 
to attenuated competence to respond to Dpn and E(spl)m 
Similar to klu, dpn is also required for supernumerary neuroblast formation in brat null 
brains (Figure 5A-C). In addition, mis-expression of dpn in Ase+ immature INPs also led 
to a significantly milder supernumerary neuroblast phenotype in wild-type as well as in 
bratDG19310/11 brains as compared to mis-expression in Ase- immature INPs (Figure 11A). 
These results prompted us to test whether Erm restricts developmental potential by 
antagonizing Dpn function. Consistent with our hypothesis, co-expression of erm 
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Figure 11: Erm-dependent restriction of developmental potential in immature INPs 
leads to attenuated competence to respond to Dpn and E(spl)m in INPs.  (A-E) Co-
expression of erm can suppress the supernumerary neuroblast phenotype induced by mis-
expression of dpn. (A) The quantification of total Wor+Ase- cells (including type II neuroblasts 
and Ase- immature INPs) per brain lobe of the indicated genotypes. Scale bar, 40 m. (F) 
Removing dpn function suppresses supernumerary neuroblast formation in erm null brains. 
The quantification of total Wor+Ase- cells (including type II neuroblasts and Ase- immature 
INPs) per clone for the indicated genotypes. Third instar larval brains carrying GFP-marked 
mosaic clones derived from single neuroblasts of the indicated genotypes were stained for 
GFP, Wor, Ase, Pros and Elav. (G) Co-expression of erm can suppress the supernumerary 
neuroblast phenotype induced by mis-expression of E(spl)m. The quantification of total type 
II neuroblasts (Dpn+Ase-) per clone for the indicated genotypes. 
completely suppressed supernumerary formation induced by mis-expression of dpn in 
Ase- immature INPs in wild-type brains (Figure 11A-C). Furthermore, co-expression of 
VP16-ermzf and dpn in Ase+ immature INPs led to a significant increase in 
supernumerary neuroblasts as compared to mis-expression of dpn alone under the 
identical conditions (Figure 11A). Finally, mis-expression of dpn in Ase+ immature INPs 
enhanced supernumerary neuroblast formation in erm hypomorphic brains (Figure 
11A,D-E). Together, these data strongly suggest that Erm restricts developmental 
potential by antagonizing Dpn function. Importantly, while not affecting the maintenance 
of type II neuroblasts  (Zacharioudaki et al., 2012; Zhu et al., 2012) (Figure 11F), 
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clonally removing the function of dpn strongly suppressed the supernumerary 
neuroblast phenotype in erm null brains (Figure 11F). Because Dpn expression is 
extinguished in immature INPs but becomes re-activated in INPs (Xiao et al., 2012), 
INPs are most likely the cells of origin for supernumerary neuroblasts in erm null brains. 
Thus, Erm-dependent restriction of the developmental potential in immature INPs leads 
to attenuated competence to respond to Dpn in INPs.  
 A recent study showed that E(spl)m also functions as a neuroblast self-renewal 
factor (Zacharioudaki et al., 2012). Similar to klu and dpn, co-expression of erm strongly 
suppressed supernumerary formation induced by mis-expression of E(spl)m in Ase- 
immature INPs in wild-type brains (Figure 11G). In addition, co-expression of VP16-
ermzf and E(spl)m in Ase+ immature INPs induced supernumerary neuroblasts, and 
mis-expression of E(spl)m in Ase+ immature INPs enhanced supernumerary neuroblast 
formation in erm hypomorphic brains (Figure 11G). Because E(spl)m expression is 
extinguished in immature INPs but becomes re-activated in INPs (Anhezini De Araujo 
and Lee, unpublished observation), E(spl)m also likely contributes to the reversion of 
INPs into supernumerary neuroblasts in erm null brains. Taken together, Erm-
dependent restriction of the developmental potential in immature INPs leads to 
attenuated competence to respond to all known neuroblast self-renewal factors in INPs.  
The BAP complex suppresses supernumerary neuroblast formation by restricting 
the developmental potential of immature INPs 
To elucidate the mechanisms by which Erm restricts the developmental potential of 
immature INPs, we characterized additional haploinsufficient loci that enhanced the 
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supernumerary neuroblast phenotype in bratDG19310/11 brains. We identified that the brm, 
mor and osa genes act as genetic enhancers of brat. Specifically, while the 
heterozygosity of brm, mor or osa did not have effects on the type II neuroblast lineage 
in wild-type brains, the heterozygosity of any of these three genes enhanced the 
supernumerary neuroblast phenotype in bratDG19310/11 brains (Figure 12A-E). Since brm, 
mor and osa encode the core components of the BAF chromatin-remodeling complex 
(Carrera et al., 2008; Mohrmann et al., 2004), we hypothesize that the BAF complex 
functions in immature INPs to suppress supernumerary neuroblast formation. 
Consistently, over-expression of a UAS-brmDN transgene, which encodes a dominant-
negative form of Brm, specifically in Ase- immature INPs enhanced the supernumerary 
neuroblast phenotype in bratDG19310/11 brains (Figure 12F-I). These data support our 
hypothesis that the BAF complex functions temporally after Brat in immature INPs to 
suppress supernumerary neuroblast formation. Consistent with the observations from a 
previous study (Neumüller et al., 2011), we confirmed that knocking down or removing 
the function of brm, osa or mor led to supernumerary neuroblast formation (data not 
presented). We ruled out the possibility that supernumerary neuroblasts induced by the 
loss of the BAP complex function arise from symmetric neuroblast division because a 
mitotic osa mutant type II neuroblast displayed normal establishment and maintenance 
of the apical-basal cortical polarity (data not presented). Together, these results strongly 
suggest that the BAF complex functions temporally after Brat in immature INPs to 
prevent supernumerary neuroblast formation. 
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Figure 12: The BAP complex functions cooperatively with Erm to restrict the 
developmental potential in immature INPs. (A-E) Reduced function of the BAP complex 
enhances the supernumerary neuroblast phenotype in brat hypomorphic brains. (E) The 
quantification of total type II neuroblasts per lobe for the indicated genotypes. Scale bar, 40 
m.(F-I) Reducing brm function in Ase- immature INPs enhances the supernumerary 
neuroblast phenotype in brat hypomorphic brains. (I) The quantification of total type II 
neuroblasts per lobe for the indicated genotypes. Scale bar, 40 m. (J-N) Reducing the 
function of the BAP complex or erm enhances the supernumerary neuroblast phenotype in 
numb hypomorphic brains. (N) The quantification of total type II neuroblasts per lobe for the 
indicated genotypes. Scale bar, 40 m.(O-Q) Reducing brm function enhances the 
supernumerary neuroblast phenotype in erm hypomorphic brains. (O-P) The high 
magnification image of the boxed area in the low magnification image is shown below. Scale 
bars, 40 m in the low magnification image and 10 m in the high magnification image.(Q) 
The quantification of total type II neuroblasts per lobe for the indicated genotypes. 
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We next tested whether the BAF complex also functions temporally after Numb 
to suppress supernumerary neuroblast formation. Similar to Brat, Numb also functions 
to prevent the newly born immature INP from aberrantly reverting into a supernumerary 
neuroblast. However, the supernumerary neuroblast phenotype displayed by a numb 
null type II neuroblast clone is too severe to test gene function in immature INPs (Xiao 
et al., 2012). By contrast, a numbNP2301/15 hypomorphic brain lobe, which contained 35.7 
± 7.5 type II neuroblasts and many INPs, provides a sensitized genetic background for 
testing gene function in immature INPs (Figure 12J, N). Consistent with our hypothesis, 
the heterozygosity of brm or mor enhanced the supernumerary neuroblast phenotype in 
numbNP2301/15 brains (Figure 12K-L; data not presented). These results strongly suggest 
that the BAF complex also functions temporally after Numb in immature INPs to 
suppress supernumerary neuroblast formation.  
Both Erm and the BAF complex function temporally after Brat and Numb in 
immature INPs to suppress supernumerary neuroblast formation. Thus, we tested 
whether Erm and the BAF complex might function cooperatively to restrict the 
developmental potential of immature INPs. Similar to the BAF complex, the 
heterozygosity of erm also enhanced the supernumerary neuroblast phenotype in 
numbNP2301/15 brains (Figure 12M-N). Most importantly, while over-expression of the 
UAS-brmDN transgene alone did not have any effect on the type II neuroblast lineage, 
over-expression of brmDN significantly increased the formation of supernumerary 
neuroblasts in erm hypomorphic brains (Figure 12O-Q). Taken together, these data 
strongly suggest that Erm and the BAF complex function cooperatively to restrict the 
developmental potential of immature INPs. 
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Figure 13: Summary models depict the role of Brat and Erm in the regulation of 
immature INPs. In wild-type brains, Erm functions temporally after Brat to restrict the 
competence of immature INPs to respond to the self-renewal network (indicated by the width 
between dotted lines of the funnel). The Self-renewal network is expressed in type II 
neuroblasts (light blue area), but is deactivated during maturation by Brat (white area). An 
Erm-dependent restriction of developmental potential (green arrows) in immature INPs, 
leads to an attenuated competence to respond to the re-activation of neuroblast self-renewal 
factors in INPs (light blue area). In brat amorphic brains, the newly born immature INPs fail 
to undergo maturation and rapidly revert into supernumerary neuroblasts. In erm amorphic 
brains, immature INPs undergo successful maturation, but their competence to respond to 
neuroblast self-renewal factors is not attenuated. Thus, upon re-expression of neuroblast 
self-renewal factors, INPs revert to form supernumerary neuroblasts. 
Discussion 
Understanding the molecular mechanisms that stably restrict the developmental 
potential of progenitor cells may lead to the identification of novel therapeutic targets to 
selectively target progenitor cell-derived tumor-initiating stem cells. However, restriction 
of developmental potential may occur while intermediate progenitor cells acquire their 
functional identity. Thus, well-established stem cell lineage information is essential for 
investigating the molecular mechanisms that restrict developmental potential. The type 
II neuroblast lineage in fly larval brains offers a unique model system to investigate the 
restriction of the developmental potential in uncommitted intermediate progenitor cells 
(Komori et al., 2014b; Weng et al., 2010; Xiao et al., 2012). In this study, we show that 
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stable restriction of developmental potential in immature INPs required a temporally 
coordinated effort of the asymmetrically inherited proteins Brat and Numb and the 
transcriptional repressor protein Erm. Brat and Numb function in the newly born 
immature INP where these two proteins prevent the reversion into a supernumerary 
neuroblast induced by the activities of self-renewal factors (Figure 13). Erm functions 
downstream of Brat and Numb in the Ase- and Ase+ immature INPs to restrict their 
genomic response to neuroblast self-renewal factors, leading to permanently attenuated 
competence to respond to these factors in INPs (Figure 13). Furthermore, we also 
identified that the BAP chromatin-remodeling complex functions synergistically with Erm 
in immature INPs to suppress the formation of supernumerary neuroblasts. Taken 
together, we propose that Erm functions cooperatively with the BAP complex to 
implement a stable restriction of the developmental potential in immature INPs by 
modifying their genome, which leads to an attenuated response to all neuroblast self-
renewal factors in INPs (Figure 13). 
Erm-dependent restriction of the developmental potential in immature INPs leads 
to an attenuated competence to respond to all self-renewal transcription factors 
in INPs 
Several pieces of evidence led us to conclude that Erm mainly restricts the 
developmental potential in the Ase+ immature INPs. Erm is primarily detected in the 
Ase- and Ase+ immature INPs but become undetectable in the INP, strongly suggesting 
that Erm functions in the Ase- and Ase+ immature INPs (Figure 8). Consistently, 
heterozygosity of erm further exacerbated supernumerary neuroblast formation 
originated from the Ase+ immature INPs in brat hypomorphic brains, and restoring erm 
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function in the Ase+ immature INPs rescued the enhancement of the supernumerary 
neuroblast phenotype (Figure 6E-I). Furthermore, restoring erm function in the Ase+ 
immature INPs also rescued the supernumerary neuroblast phenotype in erm null 
brains (Weng et al., 2010). Finally, over-expression of VP16-Ermzf, a dominant-negative 
form of Erm, in the Ase+ immature INPs significantly increased supernumerary 
neuroblasts in various genetic backgrounds (Figure 9). Although these data do not 
exclude the possibility that erm might still function in the INP, erm most likely functions 
mainly in immature INP to restrict developmental potential and suppress supernumerary 
neuroblast formation. 
Erm restricts the developmental potential of immature INPs by acting as a 
transcriptional repressor, and removing the function of klu or dpn completely 
suppressed the supernumerary neuroblast phenotype in erm null brains (Figure 9-11). 
Thus, Erm might restrict the developmental potential of immature INPs by directly 
repressing the transcription of the genes encoding neuroblast self-renewal factors or 
indirectly attenuating the competence to respond to these factors. However, Ase+ 
immature INPs in erm null type II neuroblast clones never showed a premature onset of 
Dpn expression, and over-expression of erm in neuroblasts did not affect Dpn 
expression (Weng et al., 2010). In addition, transcriptome analyses indicated that dpn 
and klu become up-regulated to a similar level in brat and erm null brains as compared 
to control brains (Komori and Lee, unpublished). Thus, it is unlikely that Erm directly 
regulates the transcription of neuroblast self-renewal genes. We favor the mechanism 
that Erm indirectly attenuates the competence to respond to these neuroblast self-
renewal factors in INPs by restricting the developmental potential in immature INPs. 
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Consistently, while over-expression of the dominant-negative VP16-Ermzf or a single 
neuroblast self-renewal factor alone induced a very weak supernumerary neuroblast 
phenotype, co-expression of VP16-Ermzf and a single neuroblast self-renewal factor led 
to a very robust supernumerary neuroblast phenotype (Figure 10-11). Taken together, 
these data strong suggest that stable restriction of developmental potential by the Erm-
dependent mechanism in immature INPs leads to attenuated competence to respond to 
the re-activation of neuroblast self-renewal factors in INPs. 
Erm restricts the developmental potential in immature INPs by repressing gene 
transcription 
The vertebrate orthologs of Erm, Fezf1 and Fezf2, regulate cortical development either 
by activating or repressing gene expression (Hirata et al., 2006; Yang et al., 2012). 
Since over-expression of either fezf1 or fezf2 can functionally substitute the role of Erm 
in the Ase+ immature INPs (Weng et al., 2010), the results from the vertebrate studies 
prompted us to investigate the molecular mechanism by which Erm restrict the 
developmental potential in immature INPs. Over-expression of ERD-Ermzf, which 
functions solely as a transcriptional repressor protein, efficiently rescued the 
supernumerary neuroblast phenotype in the Ase+ immature INPs (Figure 9). By 
contrast, over-expression of VP16-Ermzf exerted a dominant negative effect and led to a 
further increase in supernumerary neuroblasts in brat or erm hypomorphic brains 
(Figure 9). Taken together, these data strongly suggest that Erm restricts 
developmental potential in immature INPs by repressing gene transcription.  
We previously mapped the molecular lesion induced by the erm1 null allele to a 
single amino acid substitution in the third C2H2 zinc-finger of Erm, indicating that the 
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third zinc-finger is essential for the function of Erm. The C2H2 zinc-finger transcription 
factor typically binds to DNA with two or three zinc fingers (Brayer and Segal, 2008). 
Consistently, perturbing the folding of zinc-finger 2 (Ermzf2(2A)) or 4 (Ermzf4(2A)) also 
render the transgenic protein unable to restrict the developmental potential in the Ase+ 
immature INPs whereas perturbing the folding of zinc-finger 1 (Ermzf1(2A)), 5 (Ermzf5(2A)) 
or 6 (Ermzf6(2A)) had no effects (Figure 9). These data indicate that the zinc-finger 2, 3 
and 4 most likely mediate the binding of Erm to DNA. 
Erm might function cooperatively with the BAF chromatin-remodeling complex to 
modify the genomic response to neuroblast self-renewal factors 
A genome-wide RNAi study showed that knocking down the function of several subunits 
in the BAP complex results in supernumerary neuroblast formation in fly larval brains 
(Neumüller et al., 2011). We independently identified that brm, mor and osa, which 
encode the core components of the BAF complex, likely function temporally after Brat 
and Numb to restrict the developmental potential in the Ase- immature INPs (Figure 12). 
Because Brm and Osa are expressed ubiquitously in all cells in larval brains (Komori 
and Lee, data not presented), the BAP complex most likely functions cooperatively with 
a transcription factor that is uniquely expressed in the immature INPs to elicit its function 
in restricting developmental potential. Erm is the only known transcriptional factor that is 
uniquely expressed in the immature INPs, and is an excellent candidate for functioning 
cooperatively with the BAP complex to restrict the developmental potential in the 
immature INPs (Figure 8G). Consistently, reducing the function of Brm enhanced the 
supernumerary neuroblast phenotype in erm hypomorphic brains (Figure 12O-Q). Thus, 
we propose that Erm restricts the developmental potential in the immature INPs by 
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recruiting the BAP complex to specific genomic loci where the BAP complex alters the 
nucleosome structures, leading to attenuated competence to respond to the re-
activation of neuroblast self-renewal factors. Additional functional and biochemical 
experiments in the future will be required to validate this hypothesis. 
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Materials and Methods 
Fly strains 
Mutant and transgenic fly strains used include erm1, erm2 (Weng et al., 2010), kluR51 
(Kaspar et al., 2008), dpn1 (Younger-Shepherd et al., 1992), brat150 (Betschinger et al., 
2006), numb15 (Berdnik et al., 2002), Erm-GAL4(II) and Erm-GAL4(III) (Pfeiffer et al., 
2008; Weng et al., 2010), Wor-GAL4 (Lee et al., 2006b), UAS-erm-HA  (Weng et al., 
2010), UAS-klu-HA (Xiao et al., 2012), UAS-brat-myc (Xiao et al., 2012), UAS-dpn 
(Wallace et al., 2000), UAS-E(spl)m  (Ligoxygakis et al., 1998) and UAS-brmDN (Herr et 
al., 2010). The following fly stocks were obtained from the Bloomington Drosophila 
Stock Center: Oregon R, bratDG19310, bratk06028, brat11, brm2 and mor1, osa308, Act-FRT-
Stop-FRT-GAL4, tub-GAL80, UAS-mCD8-GFP, FRTG13, FRT2A and hs-flp, tub-
GAL80ts, Elav-GAL4, Act-FRT-stop-FRT-lacZ(nls), UAS-GFP(nls) and UAS-flp. 
numbNP2301 was obtained from the Kyoto stock center. 
The P[acman] BAC CH321-65B19 construct was used to generate erm-flag and 
erm-rfp transgenic fly lines following previously established protocol (Bischof et al., 
2007; Venken et al., 2009; Venken et al., 2006).  
Immunofluorescent staining and antibodies 
Larval brains were dissected in 1X PBS solution. Larval brains were fixed in 4% 
formaldehyde in 1XPBS containing 0.3% Triton X-100 (PBST) for 24 minutes and 
processed for immunofluorescent staining according to a previously published protocol 
(Weng et al., 2012). Antibodies used in this study include rabbit anti-Erm (1:100; this 
study), guinea pib anti-Ase (1:1000; this study), rat anti-Dpn (1:1000) (Xiao et al., 2012), 
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rat anti-Wor (1:1) (Lee et al., 2006b), rabbit anti-Ase (1:400) (Weng et al., 2010), mouse 
anti-Pros (MR1A, 1:100) (Lee et al., 2006c), mouse anti-Elav (1:100; 9F8A9, DSHB), 
mouse anti-Dlg (1:50; 4F3E3E9, DSHB), mouse anti-Osa (Treisman et al., 1997), rabbit 
anti-Brm (Nakayama et al., 2012), chicken anti-GFP (1:2000; cat # 1020, Aves Labs), 
chicken anti-β-Gal (1:2000; cat# 1040, Aves Labs), and rabbit anti-RFP (1:100; cat# 
600-401-379, lot# 25003, Rockland). Secondary antibodies were from Molecular Probes 
and Jackson Labs (details are available upon request). We used Rhodamine phalloidin 
(1:100; Invitrogen) to visualize cortical actin. The confocal images were acquired on a 
Leica SP5 scanning confocal microscope.  
Generation of a polyclonal antibody against Erm 
The cDNA region encoding the C-terminal 332-611 amino acids of Earmuff (Erm-C) was 
amplified by PCR and subsequently cloned into EcoRI and SalI sites of pGEX-4T-1, 
using In-Fusion HD Cloning Kit (Clontech, Cat# 639649). The primers used were: 
TGGATCCCCGGAATTCCTCACCCGCCACATGCCC (forward) and 
GGCCGCTCGAGTCGACCTAAAACACCTTGGCTATGA (reverse). The expression of 
GST-Erm-C was induced by Isopropyl β-D-1-Thiogalactopyranoside (IPTG) and purified 
using Glutathione Sepharose (GE Healthcare, Cat# 71-5027-54) and eluted by 
Glutathione. GST-Erm-C was injected into one rabbit and purified by GenScript (Hong 
Kong). 
Clonal analysis  
1. To induce the lineage clone derived from a single Ase+ immature INP or INP: 
bratDG19310/+, bratDG19310/11, erm1/+,bratDG19310/11 or erm1/2 larvae carrying the UAS-flp, 
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Erm-Gal4(III), Tub-gal80ts and Act-FRT-stop-FRT-lacZ(nls)(III) transgenes were 
genotyped at hatching, raised at 25oC and dissected at 96 hours after larval hatching. 
We empirically determined the experimental condition to obtain a small number of 
clones per brain lobe (Figure 7). 
2. The protocol to examine the expression pattern of Erm-Gal4(II) or Erm-Gal4(III) in 
brat or erm hypomorphic brains is described in the legend for Figure 5. 
3. GFP-marked mosaic clones derived from single mutant neuroblasts in the various 
genetic background was induced following a standard protocol (Lee and Luo, 2001). 
Over-expression of UAS-transgene 
Mutant larvae carrying the Wor-Gal4 and Tub-Gal80ts in combination with the UAS-
transgene were genotyped at hatching, and raised at 31oC for 72 hours after larval 
hatching. Larvae were dissected and processed for immunofluorescent staining.  
3-dimentional modeling of clones 
The model was generated using the Mimics software from Materialize. Confocal images 
were acquired using a Z-step size of 1um and the identity of each cell within a clone 
was determined  
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Chapter 3: A novel Hdac1/Rpd3-poised circuit balances 
continual self-renewal and rapid restriction of developmental 
potential during asymmetric stem cell division 
Abstract 
Stem cells divide asymmetrically to regenerate while producing intermediate 
progenitors that rapidly acquire restricted developmental potential. How the 
developmental competency of intermediate progenitors becomes precisely restricted 
remains unknown. In the fly larval brain earmuff (erm) uniquely functions to restrict the 
developmental potential of intermediate neural progenitors (INPs). Here, we elucidate a 
novel Hdac1/Rpd3-dependent mechanism through which transcriptional repressors that 
promote self-renewal maintain the erm enhancer in an inactive but poised state in 
neural stem cells (neuroblasts). Down-regulation of these self-renewal transcriptional 
repressors alleviates Hdac1/Rpd3-mediated repression, leading to the activation of Erm 
expression in immature INPs within two-hours of their birth. Erm acts as a negative 
feedback mechanism, restricting the developmental potential of INPs by repressing 
genes encoding neuroblast transcriptional activators. We propose poising the 
expression of master regulators of differentiation through active histone deacetylation in 
stem cells maintains continual self-renewal while enabling rapid restriction of 
developmental potential following asymmetric division. 
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Introduction 
To produce the astounding number and diversity of cells that comprise our body, stem 
cells undergo continual rounds of asymmetric division to self-renew while 
simultaneously giving rise to more restricted cell types. To amplify the output of each 
division, tissue-specific stem cells generate intermediate progenitors that possess a 
restricted developmental and produce exclusively differentiated cell types (Bond et al., 
2015; Paridaen and Huttner, 2014). If their developmental potential is not stably 
restrained, intermediate progenitors may become susceptible to oncogenic 
transformation (Alcantara Llaguno et al., 2015; Chen et al., 2012; Chen et al., 2010). 
Thus, the mechanisms that restrict the developmental potential of intermediate 
progenitors must be executed in an extremely efficient and robust manner following 
asymmetric stem cell division. Understanding how developmental potential becomes 
restricted in intermediate progenitors will not only improve our knowledge of 
organogenesis, but also the cell-of-origin for certain tumors.  
It has been shown that in embryonic stem cells cell-type-specific enhancers of 
key developmental regulators that control lineage restriction and cell fate commitment 
are maintained in a poised state (Calo and Wysocka, 2013; Heinz et al., 2015; Zentner 
et al., 2011). These poised enhancers are enriched for mono- and di-methylated lysine 
4 on histone H3 (H3K4me1/2), catalyzed by the Trithorax (Trx) family of proteins, and 
trimethylated lysine 27 on histone H3 (H3K27me3), catalyzed by Polycomb Repressive 
Complex 2 (PRC2). This led to the prevailing model that PRC2 prevents premature 
activation of these poised enhancers in stem cells, while Trx proteins maintain these 
enhancers for activation during lineage commitment. During the activation of poised 
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enhancers, H3K27 is demethylated to permit subsequent H3K27 acetylation (H3K27ac). 
In vertebrates, this mechanism has been attributed to the activation of poised 
enhancers during lineage commitment of embryonic stem cells and in the differentiating 
progeny of tissue-specific stem cells (Amador-Arjona et al., 2015; Lodato et al., 2013; 
Park et al., 2014; Rada-Iglesias et al., 2011). Nonetheless, whether H3K27me3 is 
essential for maintaining the inactivity of all poised enhancers and whether the 
conversion of H3K27me3 to H3K27ac indeed plays an instructive role in activating a 
poised enhancer remains unclear. It also remains untested if this stepwise mechanism 
of activating a poised enhancer is kinetically feasible to initiate expression of the fast 
activating genes that trigger restriction of developmental potential in differentiating stem 
cell progeny.  
Mechanistic investigation of how the developmental potential of intermediate 
progenitors becomes restricted has been hindered in most stem cell lineages by the 
lack of a well-defined window during which this critical change in developmental 
competency occurs. A subset of neural stem cells in the fly larval brain called type II 
neuroblasts undergo repeated rounds of asymmetric division to generate immature 
intermediate neural progenitors (INPs) that acquire restricted developmental potential 
during a maturation process lasting approximately six hours from the time of their birth 
(Bello et al., 2008; Boone and Doe, 2008; Bowman et al., 2008; Homem and Knoblich, 
2012; Homem et al., 2013; Janssens and Lee, 2014; Weng and Lee, 2011). Immature 
INPs can be unambiguously identified based on proximity to their parental type II 
neuroblast and a well characterized set of molecular markers, providing an excellent 
genetic model for investigating restriction of developmental potential in vivo (Figure 
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14A)(Bello et al., 2008; Boone and Doe, 2008; Bowman et al., 2008; Homem and 
Knoblich, 2012; Janssens and Lee, 2014; Weng and Lee, 2011). Following the 
completion of maturation, INPs re-enter the cell cycle, and undergo 5-6 rounds of 
asymmetric divisions to produce exclusively differentiating progeny (Bayraktar and 
Doe, 2013; Viktorin et al., 2011). Newly born immature INPs inherit tumor suppressor 
proteins Brain tumor and Numb through the asymmetric division of type II neuroblasts 
(Haenfler et al., 2012; Janssens et al., 2014; Xiao et al., 2012). Brat and Numb initiate 
restriction of the developmental potential by transiently down-regulating the function of 
type II neuroblast self-renewal genes klumpfuss (klu), deadpan (dpn) and Enhancer of 
split mγ (E(spl)mγ) (Berger et al., 2012; San-Juán and Baonza, 2011; Xiao et al., 2012; 
Zacharioudaki et al., 2015; Zacharioudaki et al., 2012; Zhu et al., 2012). Dpn and 
E(spl)mγ are the fly homologs of vertebrate Hes1/5 transcriptional repressors whereas 
Klu is homologous to the Wilm’s tumor 1 transcription factor in vertebrates (Imayoshi 
and Kageyama, 2014; Pei and Grishin, 2015). Understanding how down-regulation of 
self-renewal factor activities is coordinated with the activation of restricted 
developmental potential in immature INPs will likely reveal important insight into the 
regulation of all asymmetrically dividing stem cell lineages.  
The C2H2 zinc-finger transcription factor Earmuff (Erm) functions as the master 
regulator to restrict the developmental potential of INPs in the fly larval brain. 
Neuroblasts mis-expressing erm prematurely differentiate, whereas erm null INPs 
spontaneously revert into supernumerary type II neroblasts (Janssens et al., 2014; 
Weng et al., 2010). Endogenous Erm is undetectable in the self-renewing neuroblast 
and the newly born immature INP, but is detected in all remaining immature INPs in a 
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type II neuroblast lineage (Figure 14A). This strongly suggests that erm is rapidly 
activated in the immature INP after birth. The molecular mechanisms by which Erm and 
its vertebrate homologs Fezf1 and Fezf2 regulate gene transcription are likely 
conserved because over-expression of Fezf1 or Fezf2 completely rescued the 
supernumerary neuroblast phenotype in erm null brains (Weng et al., 2010). However, 
discrepancies between the reported consensus binding sequences of Erm and Fezf2 
have hindered identification of the direct targets of this family of transcription factors 
(Chen et al., 2011; Koe et al., 2014). Elucidating the regulatory mechanisms that trigger 
erm expression in immature INPs, as well as physiologically relevant Erm-binding sites 
will significantly improve our understanding of how the developmental potential of 
intermediate progenitors becomes rapidly restricted. This knowledge will also 
significantly improve our understanding of the role of the Fezf family of transcritption 
factors during neurogenesis and immune responses (Guo et al., 2013; Janssens et al., 
2014; Takaba et al., 2015),  
In this study, we defined an immature INP enhancer from the erm cis-regulatory 
region and demonstrated that it is maintained in a poised state in type II neuroblasts, 
allowing it to be rapidly activated in immature INPs within two hours of their birth. 
Contrary to expectation, the histone deacetylase Rpd3, but not PRC2, is required to 
prevent premature activation of the poised erm immature INP enhancer in type II 
neurobalsts. We found the transcriptional repressors Klu, Dpn, and E(spl)mγ function 
cooperatively through Rpd3 to promote type II neuroblast self-renewal by directly 
binding the erm immature INP enhancer and maintaining erm in an inactive but poised 
state. In addition, we found the P1-isoform of Pointed (PntP1), a type II neuoblast 
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specific transcriptional activator, also binds the erm immature INP enhancer and 
mediates activation. Consequently, rapid down-regulation of Klu, Dpn, and E(spl)mγ in 
the immature INP provides the permissive cue to activate the poised erm enhancer, 
triggering Erm expression. Lastly, we identified and validate a functional Erm-binding 
sequence that is also recognized by Fezf1 and Fezf2 in vitro, and showed that Erm 
restricts the developmental potential in immature INPs partly by directly repressing the 
expression of pntP1 and the O-isoform of grainy head (grhO) encoding neuroblast 
transcriptional activators. This work provides a novel paradigm, in which removal of self-
renewal transcriptional repressors, rather than addition of a transcriptional activator, 
rapidly activates poised gene expression. In addition, Erm is the first example of a fast-
activating poised gene that restricts the developmental potential of intermediate 
progenitors by directly repress components of the stem cell transcription factor network. 
We propose this novel HDAC1/Rpd3-poised negative feedback circuit as a highly 
efficient and robust mechanism to balance continual self-renewal with rapid restriction of 
developmental potential across asymmetric stem cell division.  
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Results 
erm is poised in the type II neuroblast but becomes rapidly activated in the 
immature INP  
To unravel the mechanisms that activate restriction of developmental potential in 
immature INPs, we examined the expression pattern of the entire collection of 9D-Gal4 
drivers that are under the control of various cis-regulatory fragments from the erm locus 
(Pfeiffer et al., 2008). We found that two partially overlapping fragments, 9D11 and 
9D10, can individually drive reporter transgene expression in immature INPs. We 
confirmed that the overlapping region can indeed drive reporter expression in immature 
INPs, mimicking the activation of endogenous Erm, and named this region the erm 
proximal enhancer (prox) (Figure 14B). In addition, we found and confirmed that the 
non-overlapping portion of 9D11 also drives reporter expression recapitulating 
endogenous Erm expression in immature INPs, and named this region the erm distal 
enhancer (dist) (Figure 14B). We focused on the erm dist immature INP enhancer and 
mapped it to a minimal 250-bp fragment (dist5E) that was sufficient to drive reporter 
expression (dist5E-gfp::luc(nls)) in a pattern reminiscent of endogenous Erm in 
immature INPs (Figure 14B-C). Thus we conclude dist5E contains many of the 
regulatory inputs that control the timing of erm activation in the immature INP and 
provides an excellent tool for dissecting the mechanisms regulating erm expression. 
To estimate the kinetics of erm activation in the immature INP, we examined the 
timing of dist5E-gfp::luc(nls) activation following asymmetric neuroblast division by live-
cell imaging. We marked the type II neuroblasts and all immature INPs with a 
mCherry(nls) transgene, and found that dist5E-GFP::Luc(nls) becomes detectable in the  
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Figure 14: The dist5E enhancer recapitulates temporal-specific activation of 
endogenous erm and is poised in type II neuroblasts. (A) Diagram showing transcription 
factor expression patterns in the type II NB lineage. The color scheme of arrows and 
arrowheads used to identify various cell types in the type II NB lineage in all figures is shown. 
(B) A summary of a subset of reporter transgenes used for mapping the minimal erm 
immature INP enhancers in the 9D11 regulatory fragment located 7 Kb from the erm 
transcription unit. Prox: proximal. Dist: distal. (C) The dist5E-gfp::luc(nls) reporter contains 
the 250-bp dist5E enhancer fragment and recapitulates the activation of endogenous Erm 
expression in immature INPs.     (legend continued on next page) 
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Figure 14 (continued): (D) Live-cell analyses of a type II NB lineage marked with 
mCherry(nls) (magenta), showing the birth of an immature INP (0:00) and the rate of dist5E-
gfp::luc(nls) (green) activation. White dotted line: type II neuroblast, Yellow dotted line: newly 
born immature INP. The time stamp indicates time after the completion of NB division. (E) 
Quantification of the relative pixel intensity of mCherry and GFP in the immature INP 
nucleus, t1/2max indicates the length of time required for dist5E-gfp::luc(nls) to achieve 50% of 
the maximum pixel intensity of GFP in the immature INP nucleus. (F) Schematic showing the 
rate at which Erm is activated during INP maturation, as well as the completion of maturation 
and re-entry into the cell cycle. (G) ChIP analysis of the relative enrichment of H3K4me2 
(red), H3K27me3 (blue), H3K27ac (green) and an IgG control (black) on the transcription 
start sites (TSS) of type II NB regulators as well as classic targets of PRC2 and Trx on 
chromatin extracted from brat mutant brains, which are highly enriched for type II NBs. (H) 
Similar ChIP analysis to (G) but performed using chromatin extracted from Ase>>aPKCCAAX 
brains, which are highly enriched for type I NBs. (I) ChIP analysis examining the enrichment 
of chromatin marks on the endogenous dist5E enhancer fragment (dist5E(endo)) and the 
transgenic dist5E enhancer fragment (dist5E(tran)) performed on chromatin extracted from 
brat mutant brains. 
immature INP less than 2 hours after neurobalst division (Figures 14D-E). We conclude 
this erm enhancer participates in the rapid activation of Erm in immature INPs within two 
hours of their birth (Figure 14F). 
This rapid activation of the erm immature INP enhancer led us to hypothesize 
that erm is maintained in an inactive but poised state in type II neuroblasts. To test this 
hypothesis, we isolated nuclear extract from larval brains enriched with either type I or 
type II neuroblasts. A brat null brain aged for 120 hours after hatching contains 
thousands of supernumerary type II neuroblasts, whereas over-expression of a UAS-
aPKCcaax transgene driven by Ase-Gal4 leads to thousands of supernumerary type I 
neuroblasts per brain lobe (Haenfler et al., 2012; Komori et al., 2014a; Komori et al., 
2014b; Xiao et al., 2012). Thus, the nuclear extract isolated from brat null brains 
provides a source of enriched type II neuroblast chromatin, and the nuclear extract 
isolated from aPKCcaax over-expressing brains provides a source of enriched type I 
neuroblast chromatin. We performed chromatin immunoprecipitation on the type I or 
type II neuroblast chromatin using specific antibodies against H3K4me2, H3K27me3, 
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H3K27ac and IgG coupled with quantitative PCR to assay the chromatin state of genes 
whose spatial expression patterns are well characterized. The transcription factors 
pntP1 and buttonhead (btd) are specifically expressed in type II neuroblasts (Komori et 
al., 2014a; Xie et al., 2014; Zhu et al.,  2011). In the type II neuroblast-enriched 
chromatin, the transcriptional start sites (TSS) of these two genes were marked by high 
levels of H3K4me2 and H3K27ac, and this combination of histone modifications is 
correlated with active transcription (Figure 14G). By contrast, in type I neuroblast-
enriched chromatin these TSS were marked by H3K4me2 and H3K27me3, histone 
modifications associated with a poised state (Figure 14H). The transcription factor grhO 
is expressed in both type I and type II neuroblasts (Almeida and Bray, 2005). As was 
expected from this expression pattern, the TSS of grhO showed H3K4me2 and 
H3K27ac marks in both type I and type II neuroblast-enriched chromatin (Figure 14E). 
Lastly, we examined the TSS of two components of the Bithorax Complex, Ultrabithorax 
(Ubx) and abdominal B (abd-B), which are classic targets of PRC2 and Trx but are not 
expressed in larval central brain neuroblasts (Bello et al., 2007). Surprisingly, the TSS 
of abd-B displayed both high levels of H3K4me2 and H3K27me3, but the TSS of Ubx 
was only enriched for H3K27me3 in both type II and type I neuroblast-enriched 
chromatin, suggesting that Ubx is in a more deeply repressed state than abd-B (Figure 
14G-H). We conclude the type I and type II neuroblast-enriched nuclear extracts provide 
a reliable platform to examine the chromatin signature of genes in distinct larval brain 
neuroblast lineages. 
We next examined the chromatin state of the erm locus in both type I and type II 
neuroblast nuclear extracts. The TSS of erm was enriched for H3K4me2 and 
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H3K27me3 in both type I and type II neuroblast-enriched chromatin (Figure 14G-H). 
The rapid activation of erm expression in immature INPs together with the TSS being 
occupied by histones that display marks associated with poised promoters suggested 
that erm is maintained in an inactive but poised state in both type I and type II 
neuroblasts. Studies in vertebrates suggest that cell-type-specific enhancers can also 
be maintained in a poised chromatin state (Amador-Arjona et al., 2015; Park et al., 
2014), prompting us to investigate whether the erm immature INP enhancer might also 
be poised in type II neuroblast to contribute to the precise pattern of erm expression. 
Consistent with this prediction, the endogenous dist5E enhancer (dist5E endo) was 
enriched for H3K4me2 and H3K27me3 (Figure 14I). Thus, maintenance of the erm 
promoter and its immature INP enhancer in a poised state in self-renewing type II 
neuroblasts likely contributes to the rapid activation of erm expression in immature INPs 
following asymmetric division.  
The histone deacetylase Rpd3 and not PRC2 prevents premature activation of the 
poised erm immature INP enhancer in type II neuroblasts 
Because the expression pattern of the dist5E-gfp::luc(nls) transgene completely co-
localizes with endogenous Erm in immature INPs (Figure 14C), we used it as a tool to 
investigate regulation of the poised erm immature INP enhancer. We first examined if 
the dist5E enhancer fragment in our reporter transgene (dist5E tran) is enriched for 
H3K4me2 and H3K27me3 in type II neuroblasts, similar to the endogenous enhancer. 
Despite the fact that the transgenic dist5E enhancer is inactive in neuroblasts similar to 
endogenous erm, the transgenic dist5E enhancer is enriched for H3K4me2 but not 
H3K27me3 in the type II neuroblast-enriched chromatin (Figure 14I). Trithorax (Trx) 
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specifically catalyzes the formation of H3K4me1 that contributes to the maintenance of 
a poised enhancer (Herz et al., 2012; Tie et al., 2014). The atypical combination of 
histone marks on the transgenic dist5E enhancer prompted us to test if Trx is required 
to maintain the dist5E-gfp::luc(nls) transgene in a poised state. Indeed, knocking down 
trx function significantly reduced the in vivo Luciferase activity of dist5E-gfp::luc(nls) 
(Figure 15A). Thus, we conclude that Trx is required for activation of the transgenic 
dist5E enhancer, and likely functions to maintain erm in a poised state in type II 
neuroblasts.  
Our finding that H3K27me3 is present on the endogenous erm immature INP 
enhancer but not on the transgenic dist5E enhancer suggested that PRC2 is not 
required to prevent premature activation of the erm immature INP enhancer in type II 
neurobalsts. This result led us to test if PRC2 is required to maintain repression of 
endogenous erm in type II neuroblasts. Enhancer of zeste (E(z)) and Suppressor of 
zeste 12 (Su(z)12) encode two core components of PRC2, and are essential for 
catalyzing the H3K27me3 histone mark (Blackledge et al., 2015; Piunti and Shilatifard, 
2016). We found that by 72 hours after clone induction Su(z)12 null type II neuroblasts 
displayed undetectable H3K27me3, and that by 96 hours after clone induction the 
majority of E(z) null clones were also H3K27me3 negative (Figure 15B, B’, E; data not 
presented). We next examined the expression of two well characterized PRC2 target 
genes Ubx and abd-B. Interestingly, we found that while Ubx and Abd-B were both 
undetectable in wild-type type II neuroblasts, only Abd-B became ectopically activated 
in Su(z)12 and E(z) null type II neuroblasts (Figure 15C, C’ and E; Figure 16A, A’; data  
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Figure 15: Rpd3-dependent deacetylation maintains the dist5E enhancer fragment 
poised in the type II neuroblast. (A) Knocking down trx function decreases the activity of 
dist5E-gfp::luc(nls) relative to the control brain as determined by a single brain luciferase 
assay (N ≥ 6 brains/time-point). The dot plots are represented as mean ± SD, *: P-value ≤ 
0.05, **: P-value ≤ 0.005. (B-D) Confocal images of 72hr wild-type and Su(z)124 mutant 
clones showing the loss of H3K27me3, ectopic expression of Abd-B, and loss of Erm 
expression in Su(z)124 mutant clones. (E) Quantification of the percentage of wild-type, 
E(z)731, Su(z)124 type II neuroblasts that are positive for of H3K27me3 and the indicated 
proteins. (F) Quantification of the percentage of wild-type, E(z)731 or Su(z)124 type II 
neuroblast clones that contain 0-8 Erm positive immature INPs. (G-I) Confocal images 
showing rpd3 mutant type II neuroblasts prematurely differentiate as indicated by reduction 
in cell diameter (54%) and lack of identifiable neuroblasts (19%). (K) Over-expression of rpd3 
but not hdac3 rescues type II neuroblast self-renewal defects in 72-hr rpd3 mutant mosaic 
clones (N ≥ 15 clones/genotype). (J-L) Reducing rpd3 function prematurely activates the 
dist5E enhancer fragment as indicated by premature expression of dist5E-gfp::luc(nls) in the 
type II neuroblast. (M) Schematic illustration of the context dependent role of PRC2 and Trx 
proteins on different target genes in type II neuroblasts, and the cooperation with 
Rpd3/HDAC1 to maintain erm in a poised sate. Dotted red line with bar: vestigial role in 
maintaining repression, Solid red line with bar: direct role in maintaining repression, Solid 
green line with arrow: direct role in activation, Dotted green line with arrow: potential role in 
activation.
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Figure 16: Analysis of chromatin 
modifiers in type II NB lineages. (A) 
Confocal images of 72hr wild-type and 
Su(z)124 mutant clones showing the lack 
of ectopic Ubx expression in type II NBs 
deficient for PRC2 components  (B) 
Quantification of type II NBs in brains 
over-expressing RNAi constructs targeting 
different histone deacetylase enzymes. 
not presented). These data are consistent 
with our ChIP qPCR results (Figure 14G-H), 
and suggest components of the Bithorax 
complex are differentially regulated in type 
II neuroblasts. In contrast, we found that 
Erm remained undetectable in Su(z)12 and 
E(z) null type II neuroblasts, and its 
expression became reduced or 
undetectable in immature INPs (Figure 
15D-F). These data indicate that PRC2 
does not prevent premature Erm expression 
in type II neuroblasts, and led us to hypothesize that the erm immature INP enhancer is 
actively repressed through an alternative mechanism. 
Because H3K27ac remained relatively low on the dist5E transgenic enhancer, 
we tested if robust histone deacetylation functions to prevent premature activation of the 
erm immature INP enhancer in type II neuroblasts. We knocked down the function of 
genes that encode histone deacetylases in neuroblasts by over-expressing UAS-RNAi 
transgenes, and determined that decreasing hdac1/rpd3 function specifically and 
reproducibly led to a reduced number of type II neuroblasts per brain lobe (Figure 16B). 
To test if rpd3 is indeed required for self-renewal, we generated mosaic clones derived 
from single rpd3 null type II neuroblasts. A wild-type clone always contained a single 
type II neuroblast that measures approximately 10 μm in diameter (Figure 15G, J). In 
contrast, more than 50% of rpd3 null type II neuroblasts displayed dramatically reduced 
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cell diameter, and 19% of rpd3 null clones lacked identifiable type II neuroblasts (Figure 
15H-J). Furthermore, over-expression of a UAS-rpd3 transgene but not a UAS-hdac3 
transgene restored self-renewal in rpd3 null type II neuroblasts (Figure 15J). These 
results strongly suggest that Rpd3-dependent histone deacetylation is essential for type 
II neuroblast self-renewal. We next tested if Rpd3 is required for maintaining the 
inactivity of the erm immature INP enhancer in type II neuroblasts. In agreement with 
our hypothesis, knocking down rpd3 function led to premature activation of dist5E-
gfp::luc(nls) in type II neuroblasts (Figure 15K-L). Thus, in contrast to PRC2, Rpd3 is 
required to prevent premature activation of the erm immature INP enhancer in type II 
neuroblasts. Together, these data indicate that robust Rpd3-dependent histone 
deacetylation works in conjunction with Trx to maintain the erm immature INP enhancer 
in a poised state in the type II neuroblast (Figure 15M).  
Self-renewal transcriptional repressors and type II neuroblast transcriptional 
activators directly regulate erm expression by binding the immature INP enhancer 
We next sought to identify specific transcription factors that control erm expression 
through the erm immature INP enhancer by using the dist5E enhancer as a platform. 
The self-renewal transcription factors Klu, Dpn and E(spl)mγ are excellent candidates 
for preventing premature activation of erm expression in type II neuroblasts because 
similar to the rpd3 mutants, klu single or dpn & E(spl) double mutant type II neuroblasts 
also prematurely differentiate (Xiao et al., 2012; Zacharioudaki et al., 2012). Consistent 
with this possibility, we identified conserved Klu, Dpn and E(spl)mγ binding sites in the 
dist5E enhancer fragment, and found that Klu, Dpn and E(spl)mγ could directly bind  
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Figure 17:  Dpn, E(spl)mγ, Klu and PntP1 directly bind and regulate activity of the 
dist5E enhancer.  (A) Electromobility shift assays (EMSA) showing the interaction of the 
DNA-binding domain of Klu (KluDBD) with a putative Klu-binding site in the dist5E enhancer 
fragment. This binding can be reduced by competition with a wild-type but not a mutant cold 
competitor probe. (B) Quantification of the number of supernumerary type II NB-like cells in 
clones over-expressing wild-type Klu, a negative control (Kluzf), ERD-Kluzf, which works as a 
constitutive transcriptional repressor, or VP16-Kluzf, which works as a constitutive 
transcriptional activator. (C) Quantification of the number of supernumerary type II 
neuroblasts in wild-type, and dpn, E(spl) or klu mutant clones over-expressing klu, dpn or 
E(spl)mγ. (D) Single brain luciferase assay showing the effect of overexpressing either Klu 
or E(spl)mγ on the activity of dist5E-gfp::luc(nls) relative to control brains (N ≥ 6 brains/time-
point). (E) Schematic illustration of dist5E transgenes containing either wild-type or mutant 
Klu and Dpn/E(spl) binding sites. (F-H) Confocal images showing the expression pattern of 
wild-type and mutant dist5E-gfp::luc(nls) transgenes in type II NB lineages. (I) Single brain 
luciferase assay comparing the relative expression level of wild-type and mutant dist5E-
gfp::luc(nls) transgenes in brat mutant brains (N ≥ 6 brains/time-point). (J) Single brain 
luciferase assay showing the effect of knocking down pnt on the expression of dist5E-
gfp::luc(nls) relative to control brains (N ≥ 6 brains/time-point). (K) A summary of 
transcription factors bound to the erm dist5E enhancer in type II NBs. All bar graphs and dot 
plots are represented as mean ± SD, *: P-value ≤ 0.05, **: P-value ≤ 0.005. 
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these sites in vitro (Figure 17A; Figure 18A-C). Dpn and E(spl)mγ are evolutionarily 
conserved transcriptional repressors, but the mechanism by which Klu regulates gene 
expression is not clear (Kobayashi and Kageyama, 2014; Taelman et al., 2004b; 
Zacharioudaki et al., 2012). We generated a series of UAS transgenes that encode Kluzf 
(the Klu DNA-binding zinc-finger motif only), VP16::Kluzf (a VP16 transcriptional 
activation domain fused to the Klu zinc-finger motif), or ERD::Kluzf (an Engrailed 
repression domain (ERD) fused to the Klu zinc-finger motif). Over-expression of the 
Kluzf or the VP16::Kluzf transgenic protein did not lead to supernumerary neuroblast 
formation (Figure 17B). By contrast, over-expression of the full-length Klu or the 
ERD::Kluzf transgenic protein triggered the formation of supernumerary neuroblasts 
(Figure 17B). These data indicate that Klu promotes type II neuroblast self-renewal by 
acting as a transcriptional repressor. We extended our analyses to examine whether Klu 
functions collaboratively with Dpn and E(spl)mγ to promote type II neuroblast self-
renewal. Removing dpn or E(spl)mγ function strongly suppressed supernumerary type II 
neuroblast formation induced by over-expression of klu (Figure 17C). Similarly, 
removing klu function strongly suppressed the supernumerary type II neuroblast 
phenotype induced by over-expression of dpn or E(spl)mγ (Figure 17C). Thus, Klu, Dpn 
and E(spl)mγ function interdependently as a transcriptional repressor network to 
promote type II neuroblast self-renewal.  
 To examine whether Klu, Dpn and E(spl)mγ promote type II neuroblast self-
renewal by repressing erm expression through the dist5E enhancer, we took the 
following two complimentary approaches. We first tested whether Klu and E(spl)mγ are 
necessary and sufficient to prevent activation of dist5E-gfp::luc(nls) in type II 
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Figure 18: Dpn, E(spl)mγ, Klu and PntP1 directly bind and regulate activity of the 
dist5E enhancer fragment. (A-B) EMSA showing the affinity of the DNA binding domain of 
E(spl)mγ or Dpn to cold competitors bearing the sequence of the three predicted sites in the 
dist5E enhancer fragment. (C) Table summarizing the results of E(spl)mγ and Dpn EMSAs. 
(D-G) Confocal images showing the effect of knocking down klu or mutating the E(spl) locus 
on expression of dist5E reporter transgenes in type II NB lineages. (H) EMSA showing the 
affinity of the DNA binding domain of PntP1 to the seven predicted sites in the dist5E 
enhancer fragment. (I) Table summarizing the results of PntP1 EMSA. 
neuroblasts. We chose to focus our analyses on klu and E(spl)mγ because Dpn and 
E(spl)mγ are members of the helix-loop-helix Orange transcription factors that regulate 
target gene expression by forming a heterodimer (Kobayashi and Kageyama, 2014; 
Taelman et al., 2004a; Zacharioudaki et al., 2012). Indeed, knock-down of klu function 
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or loss of the E(spl) locus resulted in premature activation of the dist5E-gfp::luc(nls) 
reporter in type II neuroblasts (Figure 18D-G), whereas over-expression of UAS-klu or 
UAS-E(spl)mγ was sufficient to reduce dist5E-gfp::luc(nls) activity in an in vivo 
luciferase assay (Figure 17D). Second, we examined whether Klu, Dpn and E(spl)mγ 
directly repress erm expression through the dist5E enhancer. We generated a series of 
mutant dist5E-gfp::luc(nls) reporters where the confirmed Klu-binding site or 
Dpn/E(spl)mγ-binding sites or both are mutated (Figure 17E). In contrast to the wild-
type dist5E-gfp::luc(nls) reporter, the dist5Emut Klu-gfp::luc(nls) or dist5Emut Dpn/E(spl)mγ-
gfp::luc(nls) showed detectable expression in type II neuroblasts (Figure 17F-H). To 
quantitatively assess this effect, we measured the in vivo luciferase activity of these 
reporters in brat null brains, which provided a reliable source of enriched type II 
neuroblast proteins. The dist5Emut Klu-gfp::luc(nls) or the dist5Emut Dpn/E(spl)mγ-gfp::luc(nls) 
reporter showed a significant increase in the luciferase activity relative to the wild-type 
dist5E-gfp::luc(nls) reporter (Figure 17I). In addition, the dist5Emut Klu/Dpn/E(spl)mγ-
gfp::luc(nls) reporter resulted in an even greater increase in the luciferase activity per 
brain (Figure 17I). Thus, Klu, Dpn and E(spl)mγ function cooperatively to promote type 
II neuroblast self-renewal by binding and repressing premature activation of the erm 
immature INP enhancer (Figure 17K). Furthermore, these results suggest that rapid 
down-regulation of Klu, Dpn and E(spl)mγ in immature INPs provides the permissive 
cue to allow rapid activation of the erm immature INP enhancer leading to Erm 
expression.  
Because alleviating the repression by Klu, Dpn and E(spl)mγ leads to premature 
activation of the dist5E enhancer in type II neuroblasts, we hypothesized that 
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neuroblast-specific transcriptional activators function to activate the erm immature INP 
enhancer. The ETS-1 transcriptional activator PntP1 is specifically expressed in type II 
neuroblasts and in Ase- immature INPs making it an excellent candidate to activate erm 
expression (Figure 14A). Consistent with a potential role for PntP1 in erm activation, the 
dist5E enhancer contains seven conserved PntP1-binding sites, of which five could be 
bound by PntP1 (Figure 18H-I). In addition, knocking down pntP1 function reduced the 
in vivo Luciferase activity of dist5E-gfp::luc(nls) (Figure 17J). Thes results are consistent 
with our previous findings that knocking down pntP1 function led to supernumerary type 
II neuroblast formation mimicking the erm mutant phenotype, and that the 
heterozygosity of the pnt locus enhanced the supernumary neuroblast phenotype in erm 
hypomorphic brains (Komori et al., 2014a). Thus, PntP1 most likely contributes to the 
activation of the erm immature INP enhancer (Figure 17K). Together, these data led us 
to propose a novel paradigm where removing a group of transcriptional repressors, 
rather than addition of a transcriptional activator, facilitates rapid poised enhancer 
activation in stem cell progeny following asymmetric division.  
Self-renewal transcriptional repressors function through Rpd3 to prevent 
premature activation of the erm immature INP enhancer in type II neuroblasts 
Our data indicate that both self-renewal transcriptional repressors and Rpd3-dependent 
histone deacetylation play important roles in promoting self-renewal and maintaining the 
inactivity of the erm immature INP enhancer in type II neuroblasts. Thus, we tested if 
Klu, Dpn and E(spl)mγ function through Rpd3 to promote type II neuroblast self-
renewal. We generated mosaic clones derived from rpd3 null type II neuroblasts that 
over-expressed klu, dpn or E(spl)mγ individually. While over-expression of klu induced 
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Figure 19: Dpn, E(spl)mγ and Klu function through Rpd3 to reduce H3K27ac and 
maintain the erm immature INP enhancer in a poised state in the type II neuroblast. (A-
B) Confocal images of wild-type and rpd3 mutant type II neuroblast clones overexpressing 
Klu. (C) Quantification of supernumerary type II NB in either wild-type or rpd3 mutant clones 
overexpressing Klu, Dpn, or E(spl)mγ. (D-E) Confocal images showing the global levels of 
H3K27ac in wild-type and rpd3 mutant type II NB clones. (F) ChIP assay comparing the 
enrichment of H3K27ac (green) on wild-type dist5E (tran) and dist5Erep mutant (tran) in which 
the Klu and Dpn/E(spl) sites are mutated to prevent binding. (G) Model of how transcription 
factors and chromatin modifying enzymes interact to maintain the erm immature INP 
enhancer in a poised state in type II NBs. (H) Model of how the rapid switch to an active 
state is achieved on the erm immature INP enhancer. All bar graphs and dot plots are 
represented as mean ± SD, *: P-value ≤ 0.05, **: P-value ≤ 0.005. 
supernumerary neuroblast formation in wild-type type II neuroblast clones, removing 
rpd3 function completely suppressed the supernumerary neuroblast phenotype induced 
by klu over-expression (Figure 19A-C). Similarly, removal of rpd3 function also strongly 
suppressed the supernumerary neuroblast phenotype induced by over-expression of 
dpn or E(spl)mγ (Figure 19C). Thus, the self-renewal transcriptional repressors function 
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through Rpd3 to maintain a type II neuroblast identity. Next, we tested whether Klu, Dpn 
and E(spl)mγ function through Rpd3-dependent deacetylation of H3K27 to maintain the 
erm immature INP enhancer in a poised state in type II neuroblasts. Consistent with our 
hypothesis, all cell types within rpd3 null type II neuroblasts clones displayed a drastic 
increase in H3K27ac (Figure 19D-E). Furthermore, the dist5Emut Klu/Dpn/E(spl)-gfp::luc(nls) 
transgene showed elevated H3K27ac as compared to the dist5E-gfp::luc(nls) transgene 
in type II neuroblast enriched chromatin (Figure 19F). Thus, we conclude that continual 
recruitment of Rpd3 by self-renewal transcriptional repressors maintains the inactivity of 
the erm immature INP enhancer in the type II neuroblast by keeping H3K27ac below the 
threshold required for activation (Figure 19G). In the immature INP, down-regulation of 
self-renewal transcriptional repressors relinquishes the repressive effect of Rpd3, 
leading to increased H3K27ac and activation of the erm immature INP enhancer (Figure 
19H). 
Elucidating and validating a functional Erm-binding sequence  
To elucidate how Erm restricts the developmental potential in immature INPs, we 
sought to identify a functional Erm-binding sequence. We screened a series of reporters 
that contain candidate Erm-binding sequences for their responses to the over-
expression of a series of erm transgenes in S2 cells and in larval brain neuroblasts. The 
Erm∆N transgenic protein is non-functional and serves as a negative control, and over-
expression of VP16::Erm can exert a dominant negative effect on the supernumerary 
neuroblast phenotype in erm hypomorphic brains, most likely by activating Erm target 
gene expression (Janssens et al., 2014). Only the activity of the gfp::luc(nls) reporter 
bearing a putative Erm-binding sequence (referred to as the Erm response element  
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Figure 20: Identification of an Erm/Fezf consensus DNA-binding site. (A) An illustration 
showing the reporter transgene containing either a wild-type ErmRE or a mutant ErmRE 
(ErmREmut) used in S2 cells and in vivo analyses. The reporter contains three Grainy head 
(Grh) binding sites that allow activation of reporter expression in all larval NB lineages. (B) 
Comparison of the relative expression levels of the ErmRE-gfp::luc(nls) and ErmREmut-
gfp::luc(nls transgenes in response to contransfection with either  erm, ermN, or VP16::erm 
in S2 cells. N ≥ 5 transfections/sample. (C) Comparison of the relative expression levels of 
the ErmRE-gfp::luc(nls) and ErmREmut-gfp::luc(nls transgenes in erm null brains following a 
12-hr pulse of erm, ermN, or VP16::erm. N ≥ 3 pooled samples/genotype.  (D-E) EMSA 
showing the interaction of the zinc-finger motif of Erm, Fezf1 or Fezf2 with either the ErmRE 
probe or an ErmREmut probe. (F-G) Confocal images showing the expression of ErmRE-
gfp::luc(nls) or ErmREmut-gfp::luc(nls) in type II NBs compared to INPs within the same 
lineage. (H) Quantification of the relative pixel intensity of ErmRE-GFP::Luc(nls) or 
ErmREmut-GFP::Luc(nls) in INPs relative to type II neuroblasts. N ≥ 8 lineages/reporter. Scale 
bar, 10 μm. 
(ErmRE) hereafter) identified by the FlyFactor survey 
(http://mccb.umassmed.edu/ffs/TFdetails.php?FlybaseID=FBgn0031375) could be 
repressed by over-expression of Erm but activated by over-expression of VP16::Erm in 
S2 cells (Figures 20A-B). Importantly, the ErmREmut-gfp::luc(nls) reporter, which 
contains two nucleotide substitutions in the ErmRE, was no longer responsive to 
expression of this collection of erm tansgenes in S2 cells (Figure 20A-B). Next, we 
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generated transgenic flies bearing the ErmRE-gfp::luc(nls) or ErmREmut-gfp::luc(nls) 
transgene (Figure 20A). Consistent with the observations made in S2 cells, ErmRE-
gfp::luc(nls) but not ErmREmut-gfp::luc(nls) can be repressed by over-expression Erm 
and activated by over-expression of VP16::Erm in larval brains (Figure 20C). Lastly, we 
confirmed that the zinc-finger motif of Erm, as well as the vertebrate homologs of Erm, 
Fezf1 and Fezf2, bound the ErmRE with a high affinity and specificity in vitro (Figure 
20D-E). Thus, we conclude that AAAAGAGCAAC is a consensus DNA sequence 
recognized by the Fezf family of transcription factors from Drosophila to mammals. 
 To functionally validate the specificity of ErmRE in vivo, we examined the 
expression of ErmRE-gfp::luc(nls) or ErmREmut-gfp::luc(nls) in the type II neuroblast 
lineage in wild-type brains, where endogenous Erm is exclusively expressed in Ase- and 
Ase+ immature INPs (Figure 14A). The activity of ErmRE-gfp::luc(nls) became down-
regulated in immature INPs as compared to the type II neuroblast, and its expression 
remained low in INPs (Figure 20F, H). In contrast, the expression of ErmREmut-
gfp::luc(nls) did not become down-regulated in immature INPs and INPs to a similar 
extent as ErmRE-gfp::luc(nls) (Figure 20G-H). These data indicate that the ErmRE can 
be recognized and repressed by endogenous Erm, and AAAAGAGCAAC is a functional 
Erm-binding sequence.  
Erm restricts the developmental potential in immature INPs by repressing pntP1 
and grhO transcription 
To identify the direct targets of Erm that it represses to restrict the developmental 
potential of INPs, we started by performing a microarray analyses looking for genes 
whose transcript levels became up-regulated in erm null brains. We found multiple 
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genes that encode proteins highly expressed in type II neuroblasts were significantly up-
regulated in erm mutants, and confirmed this result using qPCR (Figure 21A). To 
distinguish direct targets from indirect targets, we examined the responsiveness of 
these genes to a 12-hour pulse of transgenic Erm or VP16::Erm over-expression in erm 
null brains. We found that the transcripts for pntP1 and grhO could be repressed by 
over-expression of erm, and induced by over-expression of VP16::erm (Figure 21A). By 
contrast, over-expression of these erm transgenes did not have as pronounced an 
effect on the transcription of dpn, klu, pntP3 and grhN (Figure 21A). These data strongly 
suggest that pntP1 and grhO are direct targets of Erm.  
To test if pntP1 and grhO are indeed direct targets of Erm, we generated a 
position weight matrix for our identified Erm-binding sequence and used this to scan the 
pntP1 and grhO loci for potential Erm-binding sites. Strikingly, we found a cluster of six 
putative Erm-binding sites just upstream of the pntP1 TSS and three putative Erm-
binding sites just upstream of the grhO TSS. Consistent with the possibility that these 
clusters of sites may represent functional ErmREs, they are conserved in all Drosophila 
species. More importantly, the Erm DNA-binding domain can bind at least four of the 
sites we identified in the pntP1 locus and three of the sites we identified from the grhO  
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Figure 21: Erm restricts the developmental potential by repressing pntP1 and grhO 
transcription. (A) qPCR analysis of the relative abundance of dpn, klu, pntP1, pntP1, grhO, 
and grhN transcripts in erm null brains following a 12-hr pulse of erm, ermN, or VP16::erm N 
≥ 3 samples/genotype.(B) Comparison of the relative expression levels of both a wild-type 
pntP1 promoter that contains six conserved Erm-binding sites (PntP1-GFP::Luc(nls)) or a 
pntP1 promoter containing mutant Erm-binding sites (PntP1Erm mut-GFP::Luc(nls)) in S2 cells 
cotransfected with either erm, ermN, or VP16::erm. N ≥ 3 transfections/sample. (C) 
Comparison of the relative expression levels of both a wild-type grhO promoter that contains 
three conserved Erm-binding sites (GrhO-GFP::Luc(nls)) or a grhO promoter containing 
mutant Erm-binding sites (GrhOErm mut-GFP::Luc(nls))  in S2 cells cotransfected with either 
erm, ermN, or VP16::erm. N ≥ 3 transfections/sample. (D-E) Confocal images showing 
PntP1 expression in wild-type and erm null DM4 type II neuroblasts. Upper/lower: the upper 
or lower confocal optical section of the z-series. (F) Quantification of the percentage of cells 
per DM4 clone that are PntP1+, Ase+, or positive for both. N ≥ 5 clones/genotype.  
        (legend continued on next page) 
 
87 
    
Figure 21 (continued): (G-H) Confocal images showing GrhO expression in wild-type and 
erm null DM4 type II neuroblasts. Upper/lower: the upper or lower confocal optical section of 
the z-series. (I) Quantification of the percentage of cells per DM4 clone that are GrhO+, 
Ase+, or positive for both. N ≥ 5 clones/genotype (J-K) Confocal images of erm hypomorphic 
(erm1/2, erm-flag) larval brains mis-expressing pntP1 and grhO in Ase+ immature INP and 
INPs (Erm(III)>). Quantification of the number of type II NB-like cells in erm hypomorphic 
(erm1/2, erm-flag) larval brains mis-expressing either pntP1 or grhO alone or both pntP1 and 
grhO together in Ase+ immature INP and INPs (Erm(III)>). 
locus (Figures 22A-B). Lastly, a pntP1-luc reporter containing the pntP1 cis-regulatory 
region with wild-type, but not mutant, Erm-binding sites could be repressed by wild-type 
Erm and activated by VP16::Erm in S2 cells (Figure 21B). Similarly, only a grhO-luc 
reporter containing wild-type Erm-binding sites was activated by VP16::Erm in S2 cells 
(Figure 21C). Thus, we conclude Erm can directly bind upstream of the pntP1 TSS and 
grhO TSS.  
To determine whether Erm is required to down-regulate the expression of pntP1 
and grhO in vivo, we tested whether PntP1 or GrhO becomes mis-regulated in erm null 
type II neuroblast clones. Consistent with previous reports (Zhu et al.,  2011), PntP1 was 
detected in neuroblasts and a few immature INPs in wild-type clones, but undetectable 
in remaining cells of the type II neuroblast lineage (Figure 21D). By contrast, we 
detected ectopic PntP1 expression in all erm null type II neuroblast clones, but the 
severity of mis-regulated PntP1 expression differed among type II neuroblast lineages. 
In the erm mutant clones derived from the DL1, DM2, DM4 or DM5 type II neuroblast, 
PntP1 became ectopically expressed in virtually all cells (Figure 21E-F, Figure 22C-D, 
F). In the erm mutant clones derived from the DL2, DM1, DM3, and DM6 type II 
neuroblast, PntP1 was down-regulated in immature INPs similar to wild-type clones, 
before becoming re-expressed in INPs as they began to revert into supernumerary 
neuroblasts (Figure 22C-D, F; data not presented). Similar to PntP1, we found GrhO  
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Figure 22: Erm directly binds the pntP1 and grhO promoters to repress their 
expression during INP maturation. (A) EMSA showing the affinity of the DNA binding 
domain of Erm to cold competitors bearing the sequence of the six predicted sites in the 
PntP1 promoter. (B) EMSA showing the affinity of the DNA binding domain of Erm to cold 
competitors bearing the sequence of the three predicted sites in the GrhO promoter. (C) 
Schematic showing the position of the eight type II NB lineages in the larval brain.  
        (legend continued on next page) 
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Figure 22 (continued): (D) Quantification of the percentage of cells per clone that are 
PntP1+, Ase+, or positive for both in each of the eight type II NB lineages. N ≥ 5 
clones/genotype.  (E) Quantification of the percentage of cells per clone that are GrhO+, 
Ase+, or positive for both in each of the eight type II NB lineages. N ≥ 5 clones/genotype.  
(F) Table summarizing the severity of the erm mutant phenotype in the eight different type II 
NB lineages. 
also became ectopically expressed in erm null type II neuroblast clones in a lineage-
dependent pattern (Figure 21G-I; Figure 22C, E-F). Thus, we conclude that Erm directly 
represses PntP1 and GrhO expression in immature INPs, and that an additional partially 
redundant mechanism may work in parallel to Erm to regulate PntP1 and GrhO 
expression in a subset of type II neuroblast lineages. 
 We hypothesized that Erm restricts the developmental potential in immature INPs 
by repressing the transcription of genes important for the type II neuroblast functional 
identity. Thus, we tested if over-expression of grhO or pntP1 in late stage (Ase+) 
immature INPs as well as mature INPs, driven by Erm-Gal4(III), can trigger INPs to 
revert into supernumerary type II neuroblasts. Over-expression of either gene 
individually or in combination was insufficient to induce INP reversion in wild-type brains 
(data not presented). These results suggested that Erm repress additional 
transcriptional activators that function cooperatively with PntP1 and GrhO to promote a 
type II neuroblast identity. Thus, we over-expressed grhO or pntP1 individually or in 
combination under control of the Erm-Gal4(III) driver in erm hypomorphic brains. While 
over-expression of grhO or pntP1 alone was unable to increase the reversion of INPs 
into supernumerary type II neuroblasts, co-expression of grhO and pntP1 was sufficient 
to enhance INP reversion into supernumerary type II neuroblasts (Figure 21J-L). Thus, 
Erm restricts the developmental potential in immature INPs by acting as a negative 
90 
    
feedback regulator to repress components of the transcriptional activator network that 
maintains type II neuroblast identity (Figure 23). 
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Figure 23: A poised feedback circuit balances continual 
self-renewal of type II neuroblasts with rapid restriction of 
developmental potential in immature INPs.  
(A) Summary model showing how balancing the activity of an 
activator network with a repressor network in type II 
neuroblasts maintains the feedback repressor (Erm) in an 
inactive but poised state, facilitating continual self-renewal. 
Following asymmetric division, selective downregulation of this 
repressor network allows rapid activation of the feedback 
circuit in immature INPs which then represses components of 
the type II neuroblast activator network to stably restrict the 
developmental potential of INPs. 
Discussion 
Numerous tissue-specific stem cell types amplify the output of each division by 
producing intermediate progenitors, and precise restriction of the developmental 
potential of intermediate progenitors is critical for proper differentiation following 
asymmetric stem cell divisions. Elucidating the molecular mechanisms that restrict the 
developmental potential in intermediate progenitors will provide critical insight into the 
precise generation of specific differentiated cell types, as well as the susceptibility of 
intermediate progenitors to forming tumor-initiating cells when these mechanisms go 
awry. We have 
demonstrated that in 
type II neuroblasts, self-
renewal transcriptional 
repressors recruit the 
histone deacetylase 
Rpd3 to maintain the 
immature INP enhancer 
of erm in an inactive but 
poised state (Figure 17-
19). Following 
asymmetric neuroblast 
division, self-renewal 
transcriptional repressors become rapidly downregulated by asymmetrically segregated 
cell fate determinants in the immature INP (Haenfler et al., 2012; Janssens et al., 2014; 
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Xiao et al., 2012). Our results demonstrate this cue initiates the restriction of INP 
developmental potential by relinquishing Rpd3 activity on the poised erm enhancer and 
allowing for Erm activation in immature INPs within two hours of their birth. Once 
activated, Erm prevents INPs from reverting into supernumerary type II neuroblasts by 
forming a negative feedback mechanism that represses the expression of neuroblast 
transcriptional activators. This highly streamlined mechanism directly couples the down-
regulation of self-renewal repressor activities to the activation of a master regulator of 
differentiation, and ensures that the developmental potential of an uncommitted 
intermediate progenitor becomes rapidly restrained prior to its entry into the next cell 
cycle (Figure 23). Previous studies in human and mouse embryonic stem cells revealed 
that PRC2 is bound to the promoter of Fezf2, a vertebrate homolog of erm, and the 
Fezf2 neurogenic enhancer displays H3K4me1 and H3K27me3 (Boyer et al., 2006; 
Eckler et al., 2014; Rada-Iglesias et al., 2011; Shim et al., 2012). This suggests 
embryonic stem cells maintain Fezf2 in a poised state for subsequent activation in the 
developing nervous system. Thus, the poised circuit we describe is likely conserved in 
vertebrates, and may regulate restriction of the developmental potential of intermediate 
progenitors in vertebrate tissue-specific stem cell lineages.  
Maintaining the cell type-specific enhancer of a master regulator of differentiation 
in a poised state in self-renewing stem cells 
To meet the fast pace of development and the fluctuating demands of tissue 
homeostasis, a multipotent intermediate progenitor needs to rapidly acquire restricted 
developmental potential before re-entering the cell cycle to produce differentiated cell 
types. Maintaining the cell type-specific enhancers of master regulators of lineage 
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commitment and differentiation in a poised chromatin state has been suggested to 
facilitate their efficient activation in stem cell progeny (Heinz et al., 2015). The prevailing 
model of poised enhancer regulation is that the H3K4me1/2 and H3K27me3 histone 
marks, and their associated chromatin modifiers, serve to maintain the primed state of 
poised enhancers while preventing premature activation respectively. This paradigm 
predicts that removing PRC2, which catalyzes H3K27me3 formation, should lead to 
premature activation of a poised enhancer and de-repression the associated gene. 
Surprisingly, we find that although the transgenic dist5E enhancer is inactive in type II 
neuroblasts it does not display H3K27me3 (Figure 14I), and removing PRC2 function 
led to loss of endogenous Erm expression instead of premature activation of Erm 
expression (Figure 15D-F). This indicates PRC2 is not required to maintain repression 
of the poised erm immature INP enhancer in type II neuroblasts. By contrast, removing 
Hdac1/rpd3 function led to premature activation of the transgenic erm enhancer in type 
II neuroblasts and resulted in premature type II neuroblast differentiation, likely due to 
de-repression of Erm expression (Figure 15G-L). Based on these findings, we propose 
a new model in which Hdac1/Rpd3 but not PRC2 is required to maintain repression of 
the poised enhancer of a master regulator of differentiation in self-renewing stem cells. 
One possible explanation for this apparent difference in the role of PRC2 during poised 
gene regulation is that PRC2 functions in a context dependent manner on different 
poised enhancers, or even on the same poised enhancer in distinct stem cell types. Our 
characterization of the kinetics of dist5E-GFP::Luc(nls) activation in vivo demonstrated 
the poised erm immature INP enhancer is activated within two-hours of stem cell 
division, mimicking endogenous Erm expression (Figure 14C-F). Thus, we propose the 
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erm immature INP enhancer is part of a specific class of fast-activating poised 
enhancers that rely primarily on deacetylation by Hdac1/Rpd3 to maintain their 
repression.  
Activation of a poised enhancer of a fast activating gene in uncommitted 
intermediate progenitors 
The prevailing model suggests activation of a poised enhancer occurs in a sequential 
manner and is initiated by the binding of a signal-dependent transcriptional activator 
followed by the recruitment of a histone demethylase to remove H3K27me3 and then a 
histone acetytransferase to acetylate H3K27 (Heinz et al., 2015; Park et al., 2014). 
However, this stepwise and relatively cumbersome mechanism is likely not appropriate 
for a fast-activating poised gene like erm that is expressed in immature INPs within two-
hours of their birth. In this study, we report two novel findings that enable rapid 
activation of a master regulator of differentiation whose expression is highly time-
sensitive. First, multiple self-renewal transcriptional repressors directly bind the erm 
immature INP enhancer in type II neuroblasts and work cooperatively to maintain the 
poised state through continual deacetylation of H3K27 by Rpd3 (Figure 17, 19). This 
result strongly suggests the H3K27 histone acetyltransferase (HAT) is already present 
on the erm immature INP enhancer in type II neuroblasts (Figure 19G). One attractive 
possibility is that lineage-specific transcriptional activators that are expressed in type II 
neuroblasts and immature INPs, such as PntP1, mediate recruitment of the H3K27 HAT 
to the erm immature INP enhancer. This would explain why this Erm is specifically 
expressed in the progeny of type II neuroblasts. Second, selective downregulation of 
self-renewal transcriptional repressor proteins alleviates Rpd3-mediated deacetylation, 
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allowing the rapid accumulation of H3K27ac on the poised enhancer and activation of 
Erm expression in immature INPs (Figure 19H). This suggests the incorporation of new 
histones during DNA replication, together with continual recruitment of a HAT, may 
bypass active demethylation of H3K27 as a prerequisite for activation of fast-activating 
poised enhancers. Directly coupling the stem cell transcription factor network to 
activation of the master regulator of differentiation through its poised enhancer, and 
selectively downregulating self-renewal transcriptional repressors in stem cell progeny, 
provides a robust and efficient strategy to ensure rapid restriction of developmental 
potential following asymmetric division. We propose the regulatory logic described here 
is likely broadly applicable to numerous stem cell types in both Drosophila and 
vertebrates.  
Regulation of restricted developmental potential 
Restricting the developmental potential in intermediate progenitors involves restraining 
the mechanisms that endow stem cells with their unique functional properties. Our study 
identified pntP1 and grhO as direct targets of Erm (Figure 21-22). Co-expression of 
pntP1 and grhO was sufficient to enhance INP reversion into supernumerary type II 
neuroblasts in hypomorphic erm mutant brains (Figure 21J-L), suggesting that Erm 
restricts the developmental potential of INPs by directly repressing components of the 
type II neuroblast transcription factor network (Figure 23). Interestingly, PntP1 is also 
required for activating the erm immature INP enhancer, and loss of pntP1 function leads 
to supernumerary type II neuroblast formation mimicking the erm null phenotype 
(Komori et al., 2014a). Thus, Erm-dependent restriction of developmental potential most 
likely also dismantles the mechanisms that promote activation of its own enhancer. Erm 
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is the first example of a fast-activating poised gene that restricts the developmental 
potential in intermediate progenitors by acting as a negative feedback circuit and 
repressing components of the stem cell transcription factor network (Figure 23). 
Identifying similar regulatory circuits that balance self-renewal with differentation in other 
stem cell lineages will require in-depth knowledge of (1) the core stem cell transcription 
factor network, (2) the functional consequence of the binding of specific transcription 
factors to the poised enhancers of pro-differentiation genes (i.e activation vs. 
repression), and (3) the mechanisms that alter the activity of components of the stem 
cell transcription factor network in stem cell progeny. Ultimately, understanding these 
poised regulatory circuits will facilitate the precise generation of specific differentiated 
cell types for regenerative medicine, and provide insight into how specific oncogenic 
lesions contribut to the formation and growth of stem cell and intermediate progenitor 
derived tumors. 
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Figure 24: Novel methods to study enhancer regulation in the Drosophila larval brain. 
(A) Schematic of the VanGlow vector used for the analysis of cis-regulatory elements in both 
S2 cells and the larval brain throughout this study. (B) Illustration of the two different reporter 
proteins used in the VanGlow vector series. (C) Gel showing the optimization of the fixation 
and sonication conditions used for ChIP on larval brain tissue. A 10 minute fix and 60 minute 
sonication where used throughout this study because this was the only condition that yielded 
DNA fragments ranging in size from 100-500 bp. 
Materials & Methods 
Construction of VanGlow reporter vectors.  
We created a new transgenic reporter vector (VanGlow) to facilitate rapid cloning of cis-
regulatory elements upstream of either a GFP::Luciferase(nls) or mCherry::Renilla(nls) 
reporter for applications in transgenic fly lines as well as in tissue culture cells (Figure 
24A-B). Synthetic nucleotides encoding a GFP::Luciferase(nls) or mCherry::Renilla(nls) 
(codon optimized for expression in Drosophila) and a yeast transcriptional terminator 
flanked by HindIII sites were generated by GeneArt™ (Thermofisher scientific). These 
constructs where then cloned into the BPGw (Addgene #17574) and BPGUw (Addgene 
#17575) vectors using the HindIII sites to replace GAL4, generating the promoter and 
enhancer VanGlow vectors respectively. 
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Fly strains 
Wild type and mutant dist5E-gfp::luc(nls) and dist5E-rfp::ren(nls) transgenic fly lines 
were generated by Gateway® cloning the wild-type and mutant sequences (generated 
as 500bp gBlocks®  from IDT) into the VanGlow vector. The ermRE-gfp::luc(nls) and 
ermREmut-gfp::luc(nls) reporter lines were generated using a similar approach, except 
synthetic nucleotides bearing six copies of a putative Erm-binding motif and three Grh 
consensus binding motifs (included to increase basal expression levels) with a random 
eight nucleotide spacer between each motif were used as templates. Constructs were 
then inserted into the PBAC (yellow[+]-attP-3B)VK00033 docking site via ϕC31 
integrase-mediated transgenesis (Bischof and Basler, 2008). Additional fly lines used in 
this study include erm1, erm2  (Weng et al., 2010), brat150 (Betschinger et al., 
2006),  Erm-GAL4(III) (Pfeiffer et al., 2008), Wor-GAL4 (Lee et al., 2006b), Ase-
Gal80 (Neumüller et al., 2011), UAS-klushmiR (Berger et al., 2012), UAS-klu::HA (Xiao et 
al., 2012),  UAS-dpn (Wallace et al., 2000), UAS-E(spl)mγ, FRT82B 
P[gro+]Df(3R)E(spl)b32.2 (gift from C. Delidakis), dpn1 (gift from Y.Jan), kluR51 (Kaspar 
et al., 2008), UAS-erm::HA, UAS-erm∆N, UAS-VP16::erm (Janssens et al., 2014), UAS-
pntP1 (Zhu et al.,  2011), UAS-grhO’ (gift from S. Bray). The following fly stocks were 
obtained from the Bloomington Drosophila Stock Center: Oregon R, E(z)731, FRT2A, 
Su(z)124, FRT2A, brat11, Act-FRT-Stop-FRT-GAL4, tub-GAL80, FRT82B, 
FRT2A and hs-flp, tub-GAL80ts, Elav-GAL4, 12E9-GAL4, UAS-GFP(nls), UAS-flp , 
UAS-mCD8-GFP, and UAS-dcr2. We obtained the following stocks from the 
Vienna Drosophila RNAi Center: UAS-pntRNAi (7171), UAS-trxRNAi (108122), UAS-
rpd3RNAi.  
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Immunofluorescence staining and antibodies 
Larval brains were dissected in PBS, fixed in 100 mM PIPES (pH 6.9), 1 mM EGTA, 
0.3% Triton X-100, 1 mM MgSO4 containing 4% formaldehyde for 23 minutes and 
processed for immunofluorescence staining according to a previously published 
protocol (Weng et al., 2010). Antibodies used in this study include rabbit anti-Erm 
(1:100), and guinea pig anti-Ase (1:1000) (Janssens et al., 2014), rat anti-Dpn (1:2) and 
rat anti-Wor (1:2)(Lee et al., 2006b), rabbit anti-Ase (1:400) (Weng et al., 2010), rabbit 
anti-PntP1 (1:600; Skeath JB), rat anti-Grh (1:1000; Thor S.), rabbit anti-H3K27me3 
(1:500; 07–449; Millipore, Billerica, MA), mouse anti-Ubx (1:500; FP3.38, DSHB), 
mouse anti-Abd-B (1:500; 1A2E9, DSHB), mouse anti-Dlg (1:50; 4F3E3E9, DSHB), 
chicken anti-GFP (1:2000; cat. no. 1020, Aves Labs), and rabbit anti-RFP (1:100; cat. 
no. 600-401-379, Rockland). Species-specific fluorophore-conjugated secondary 
antibodies (Jackson ImmunoResearch, 703-545-155, 112-605-167; Life Technologies, 
A-11034, A-11035, A-11074, A31553, A-31556) were used at 1:500. We used 
Rhodamine phalloidin (1:100; Invitrogen) to visualize cortical actin. The confocal images 
were acquired on a Leica SP5 scanning confocal microscope. 
Chromatin Immunoprecipitation 
We dissected groups of 100 brains from either brat mutant or ase>aPKCCAAX  larvae 
aged for 5 days at 31°C directly into Schneider's medium then fixed in cross-linking 
solution (1% methanol free-formaldehyde, 50mM HEPES(pH 8), 1mM EDTA, 0.5mM 
EGTA, 100mM NaCl) for 10 min. We stopped fixation by washing twice with Glycine 
solution (0.125 M, 0.01% Triton X-100) in PBS at room temperature for 5 min. Samples 
were then washed twice with wash buffer A (10mM HEPES(pH 7.6), 10mM EDTA, 
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0.5mM EGTA, 0.25% Triton X-100) and twice with  wash buffer B (10mM HEPES(pH 
7.6), 1mM EDTA, 0.5mM EGTA, 200mM NaCl, and 0.01% Triton X-100) and then snap 
frozen in liquid nitrogen. To obtain more than 2 × 106 supernumerary type II 
neuroblasts, we pooled 400 brains/ChIP. Samples were then homogenized in 
200ul/ChIP SDS lysis buffer (1% SDS, 1 mM PMSF, 50 mM Tris–HCl pH8.1, 10 mM 
EDTA, 10mM Na-butyrate) containing proteinase inhibitors (Roche, Basel, Switzerland). 
The nuclear extracts were disrupted by sonication (60 cycles of sonicating for 30 s with 
30 s intervals) using a Diagenode, Bioruptor xL. This ChIP protocol is optimized for 
larval brain tissue to yield chromatin fragments that range in size from 100-500bp 
(Figure 24C). Ten percent of the sonicated sample was stored for INPUT. The rest of 
the sonicated chromatin was incubated with antibodies in ChIP dilution buffer (0.01% 
SDS, 1.1% Trition X-100, 1.2 mM EDTA, 16.7 mM Tris–HCl pH8.1, 167 mM NaCl) on a 
rotator at 4°C overnight. Samples were then incubated on a rotator with 60 uL Protein A 
agarose/salmon sperm DNA beads (16–157; Millipore, Billerica, MA) at 4°C for 4-6 hrs, 
washed twice with low salt immune complex wash buffer (0.1% SDS, 1% TritonX-100, 2 
mM EDTA, 20 mM Tris–HCl pH8.1, 150 mM NaCl) for 5 min, once with high salt 
immune complex wash buffer (0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM Tris–
HCl pH8.1, 500 mM NaCl) for 5 min, once with LiCl immune complex wash buffer (0.25 
M LiCl, 1% NP40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris–HCl pH8.1) for 5 min, 
and twice with TE buffer, and then were eluted from beads in elution buffer (10% SDS, 
0.1M NaHCO3) for 5 min. Cross-linking of chromatin–protein complex was reverted at 
65°C overnight. Samples were treated with RNase A at 55°C for 1 hr and incubated with 
2 μg of proteinase K at 45°C for 2 hr. Samples were cleaned up by phenol:chloroform 
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Target Region Forward Primer Reverse Primer 
pntP1(TSS) gcggcagccaatcccactt ctagcagcgacgaacggtataaaaagat 
btd(TSS) tatttgaattatgcacgctccctctt attctcattatccccttgcccactca 
grhO(TSS) aaccgacccgccccctcaac gctgcttttggccgcttctaatgtg 
erm(TSS) gtcgccccatccaaatcaagtgtg cagtgagcagagaccgcccctaaaa 
Ubx(TSS) aggcgcccaccccgataaactta tgctctgccgactcaactcactc 
abd-B (TSS) cctccccgcccccattcc tgctccaagtcacagggggtcatc 
dist5E (endo) ttgggaaagaaaagcgcacataac gccaaagtccccgcaacgaa 
dist5E (tran) tatatttgtgcggctgtgacgac aatgctttttctttctacggttgttg 
neg control gaaccgcaggcaggaacaagaaga gtcaaggaatcggaaaataaaaacagg 
 
Table 1: Primers used for ChIP qPCR.  The sequences of forward and reverse primers 
used for ChIP qPCR are indicated.  
extraction followed by EtOH precipitation. Samples were resuspended in 75 μl of water. 
1.5 μl of sample was used in each qPCR reaction. Antibodies used in this experiment 
were rabbit anti-H3K4me2 (1:500; 07–030; Millipore, Billerica, MA), rabbit Anti- 
H3K27me3 (1:500; 07–449; Millipore, Billerica, MA), rabbit Anti-H3K27Ac (1:500; 
ab4729; Abcam) and rabbit IgG (1:500; ab46540; Abcam). Specific primer sets used for 
ChIP qPCR are listed in Table 1. 
Luciferase Assays 
S2 Cells- 3XC-terminal-HA-tagged erm, erm∆N, and VP16-erm were cloned into the 
pAc5.1/V5-His-A expression vector (ThermoFisher Scientific) for constitutive expression 
under the control of the actin5 promoter. A total of 0.5 mL of 10 × 106 cells/mL S2 cells 
was seeded in serum free Schneider’s medium (Sigma, St. Louis, MO) in 12-well plates. 
1 hour later, cells were co-transfected with 700ng pcDNA3, 100ng of VanGlow 
luciferase reporter plasmid, 150ng of the pAC5.1 expression vector, and 10ng of pRL-
CMV, which serves as an internal control. Approximately 6 hrs after transfection 0.5mL 
of 10%FBS Schneider’s Medium was added. Cell lysis and luciferase assays were 
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performed 24 h after transfection using the Dual Luciferase Assay System (Promega) 
and a PerkinElmer's EnSpire Multilabel Plate Reader. 
Drosophila brains- single brains were dissected directly into 65ul of Passive Lysis 
buffer (Promega) and triturated to homogenize tissue, except for the analysis of ermRE-
gfp::luc(nls)and ermREmut-gfp::luc(nls)for which four brains were pooled per sample. 
Luciferase assays were preformed using standard procedures.  
Protein Expression and Purification 
The DNA-binding domains of Erm (amino acids 316-482), Fezf1 (258-424), Fezf2 (270-
436), Klu (560-708), PntP1 (499-604), and E(spl)mγ (2-86) were cloned into pMALc2x 
(New England Biolabs).  Following induction, MBP-fusion proteins were purified from E. 
coli in column buffer (20 mM Hepes (pH 7.6), 0.2 M NaCl, 1 mM EDTA, 10 mM β-
mercaptoethanol, 2 mM PMSF) using amylose resin (New England Biolabs). After 
washing, protein was eluted with 20 mM maltose in elution buffer (20 mM Hepes (pH 
7.6), 100 mM NaCl, 1 mM EDTA, 10% glycerol).  Dpn (28-106) was cloned into 
pGEX6p1.  GST-Dpn was purified in column buffer (25 mM Hepes (pH 7.6), 0.15 M 
NaCl, 10% glycerol, 1 mM EDTA, 10 mM β-mercaptoethanol, 2 mM PMSF) using 
Glutathione HiCap Matrix (Qiagen). After washing, protein was eluted with 20 mM 
glutathione in column buffer.  Protein concentrations were measured by Coomassie 
stained SDS-PAGE gels.  Known concentrations of bovine serum albumin were used as 
a standard or proteins were standardized to previously determined concentrations of 
proteins from an earlier preparation.   
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Electromobility Shift Assays 
EMSAs were performed as previously described (Hamm et al., 2015).  40fmol Cy5-
labeled oligonucleotide probe and 75ng poly(dI-dC) were used in each reaction.  
Amounts of recombinant protein used per reaction were as follows: 10 pmol MBP-Klu560-
708, 0.25 pmol MBP-PntP1499-604, 5 pmol MBP-E(spl)2-86, 8 pmol GST-Dpn28-106, 1-8 pmol 
MBP-Erm316-482, 1-8 pmol MBP-Fezf2270-436.  For competition experiments, unlabeled 
competitor oligonucleotide probes were used at 10x, 250x, and 500x the concentration 
of the Cy5-labeled probe.  All samples were incubated on ice for 20 min and 
electrophoresed for 35 min at 150 V and 4°C in 4% polyacrylamide gels (29:1). The 
sequence of the Cy5-labeled probes containing a canonical transcription factor binding 
site were as follows, with the DNA-binding element in bold and the bases substituted to 
mutate the binding sequence underlined: Erm/Fez2f: 
TGTCAGTGAAAAGAGCAACTAGCAACG, Dpn/E(spl): 
AATCGCAGGATCGCGTGTCAACAACCG, Klu: 
ATGATCGGCACACCGACGCAGGATCCT, PntP1: 
ATATAATTAACCGGAAGCGCGGCACAC. 
 
Time-lapse imaging of type II neuroblasts. 
Time-lapse experiments were performed on transgenic animals expressing a single 
copy of dist5E-gfp::luc(nls) and dist5EKlu/Dpn/E(spl)-mcherry::ren(nls). Larvae hatched from 
synchronized egg collections were raised at 25˚C for 96h (late third instar stage). Larval 
brain explants were prepared for time-lapse microscopy as described (Siller et al., 2005) 
with the following modifications. Larval brains were cultured in D22 media (pH 6.95) 
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supplemented with 7.5% bovine growth serum and 10mM ascorbic acid. Time-lapse 
acquisition was performed on a Leica SP8 laser scanning confocal microscope 
equipped with 488 nm and 543 nm laser lines used for GFP and RFP excitation 
respectively. GFP/RFP z-stack series (8-10 focal planes with 1.5 m spacing) were 
acquired at 30s intervals using sequential line scanning mode.  
Acquired images series were processed using Fiji (Schindelin J et al., 2012). To 
compensate for moderate fluorophore photobleaching, mean whole volume 
fluorescence intensity was determined for the first (GFPt0 and RFPt0 and last time point 
(GFPtn and RFPtn) in each time-lapse series. The bleaching coefficient bcoeff was 
calculated separately for each fluorophore channel as GFPt0/GFPtn and RFPt0/RFPtn.  
For composition of the time-lapse movies, image intensity levels were linearly scaled for 
each timepoint (tx) and fluorophore channel using the factor bcoeff * (tx / tn). To reduce 
pixel noise, a Gaussian filter (sigma=1) was applied to each image after bleaching 
correction.  
qPCR analysis of transcript abundance in erm mutant brains 
 Total RNA was extracted following the standard Trizol RNA isolation protocol (Life 
technologies, Grand Island, NY) and cleaned by the RNeasy kit (Qiagen, Venlo, 
Netherlands). First strand cDNA was synthesized from the extracted total RNA using 
First Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche, Basel, Switzerland). qPCR 
was performed using ABsolute QPCR SYBR Green ROX Mix (Thermo Fisher Scientific 
Inc., Waltham, MA). Data were analyzed by the comparative CT method, and the 
relative mRNA expression is presented. Specific primer sets used for qPCR are listed in 
Table 2. 
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Gene Forward Primer Reverse Primer 
Rp49 atcggttacggatcgaacaa gacaatctccttgcgcttct 
dpn catcatgccgaacacaggtt gaagattggccggaactgag 
klu caacaataatgagacccactcc gatcttcatcctgttcggcatc 
pntP1 aatctggtgggggcgttgag gctgttgttgatgcggtcgtgt 
pntP3 gatcgtcgtcccccttttta gcagcggcggtagcatc 
grhO gccggccagcacgaggtctttgta tgctgctgctgttgctggtggtga 
grhN cacgggctccattgtctcctct gttctctgctggatgctgttcacg 
 
Table 2: Primers used for qPCR analysis of transcription factor expression levels.  
The sequences of forward and reverse primers used for qPCR are indicated.  
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Chapter 4: Discussion and future directions 
Although PcG and TrxG genes were first discovered by genetic studies in Drosophila 
(Kennison, 1995), whether Drosophila stem cells maintain developmental regulators of 
lineage-commitment and differentiation in a poised chromatin state remained unclear.  
In Drosophila, this poised chromatin state had only been described in wing disks 
(Schertel et al., 2015), which do not possess a bona fide stem cell population. Thus, our 
finding that Drosophila type II neuroblasts maintain erm, the master regulator of INP 
commitment, in a poised chromatin state provides an exciting starting point for future 
investigation. 
 The power of Drosophila genetics combined with the ability to unambiguously 
identity all cell types within type II neuroblast lineages will enable mechanistic 
investigation of numerous aspects of the poised chromatin model that have remained 
intractable in other systems. Our work has already revealed self-renewal repressor 
proteins directly bind the erm immature INP enhancer and prevent premature activation 
through HDAC1/Rpd3 (Janssens et al., 2016) (see Chapter 3). Continuing to study the 
sequence of the erm immature INP enhancer will reveal additional transcription factor 
inputs that prime this enhancer for activation. Combining this knowledge with functional 
genetic studies will facilitate identification of the chromatin modifiers they interact with to 
activate erm expression.  Second, accumulating evidence suggests that PcG genes 
have an important role in establishing the 3-dimensional architecture of the genome 
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(Bantignies et al., 2011; Sexton and Cavalli, 2015; Sexton et al., 2012). Our results 
suggest that in contrast to the canonical role of PRC2 to maintain transcriptional 
repression, PRC2 likely facilitates activation of endogenous erm. An attractive 
explanation is that PRC2 maintains the erm locus in a confirmation that facilitates 
subsequent activation. Examining the effect of PcG genes during the maintenance of 
the intra-genic 3D conformation of the erm locus will likely clarify the function of PcG 
genes during poised gene regulation. Lastly, our preliminary data suggests numerous 
components of the INP temporal cascade, which specifies the sequential generation of 
distinct types of neurons (Bayraktar and Doe, 2013), are also maintained in a poised 
state. This suggests these genes may function in parallel to the erm poised feedback 
circuit as a poised feedforward circuit to precisely specify the functional properties of 
INPs. Different components of this temporal cascade are activated at different times in 
INPs (Bayraktar and Doe, 2013), including fast-activating genes (such as Dichaete (D)) 
that are activated with very similar kinetics to erm in immature INPs, as well as genes 
that are activated only upon the completion of INP maturation (such as odd paired (opa) 
and apterous (ap)). This provides an exciting opportunity to study how distinct classes 
of poised genes are regulated and organized within the 3D space of the nucleus. The 
outcome of this line of investigation will likely continue to break new ground in the field 
of poised gene regulation, and provide novel insight into the universal mechanisms that 
control stem cell biology.   
Identifying novel mechanisms that activate the poised erm enhancer.  
Elucidating how stem cell transcription factor networks regulate the activity of poised 
enhancers is critical to understanding the balance between self-renewal and 
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differentiation. Our work shows that the self-renewal transcriptional repressors Klu, Dpn, 
and E(spl)mγ directly bind the erm immature INP enhancer (dist5E) and prevent 
premature activation through HDAC1/Rpd3, and that the lineage-specific activator 
PntP1 primes this enhancer for activation (Janssens et al., 2016) (see Chapter 3). 
However, our preliminary data suggest that additional activator inputs must exist in the 
dist5E enhancer. More specifically, mutation of the five PntP1 binding sites in dist5E did 
not render the enhancer inactive in type II neuroblast lineages (Figure 25A-C). By 
looking for additional conserved transcription factor binding motifs in the erm dist 
enhancer, we identified multiple putative binding sites for additional components of the 
type II specific activator network including Btd/Sp1, which share a similar binding motif, 
and Dll (Figure 25D). Consistent with the functional role of PntP1 during erm activation, 
reducing PntP1 activity by RNAi was sufficient to enhance the supernumerary 
neuroblast phenotype in erm hypomorphic mutant brains (Figure 25E-G). To determine 
whether Btd, Sp1 or Dll also contribute to activation of the poised erm enhancer we 
propose to take a combination of similar approaches. First, we will test whether 
knocking-down btd, Sp1 or Dll also enhances the supernumerary neuroblast phenotype 
in erm hypomorphic mutant brains. Second, we will examine the consequence of 
mutating the Btd/Sp1 or Dll binding sites on the expression of the dist5E transgenic 
reporter. It is possible that PntP1, Btd, Sp1 and Dll work in a semi-redundant manner to 
activate the erm immature INP enhancer. Thus, we will also generate transgenic 
reporters in which the PntP1, Btd/Sp1, and Dll binding sites are mutated in combination. 
These experiments will likely elucidate the transcription factor inputs that activate the 
poised erm enhancer, demonstrate that type II neuroblast specific transcription factors 
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regulate common targets, and provide a useful tool to examine how the chromatin state 
of poised enhancers changes when the activator inputs are removed (see below).  
 Transcription factors often regulate expression of their target genes through 
recruitment of chromatin modifying enzymes. Genome-wide association studies have 
found that the histone acetyltransferase (HAT) p300/CBP localizes to the majority of 
poised enhancers (Rada-Iglesias et al., 2011). Thus, the prevailing model of poised 
enhancer activation includes acetylation of H3K27 by p300/CBP (Heinz et al., 2015), but 
this has yet to be functionally tested. In contrast to what this model would predict, we 
find that knocking down the function of CBP suppresses, rather than enhancers, the 
supernumerary neuroblast phenotype in erm hypomorphic mutant brains (Figure 25E, F, 
H). However, 8-12 type II neuroblast can still be found in these brains, indicating that 
reducing the function of CBP is not simply causing type II neuroblasts to die or 
prematurely differentiate. This strongly suggests CBP may be required for efficient INP 
reversion in erm mutants, and that an alternative HAT mediates the activation of the 
poised erm enhancer. To identify this HAT, we will reduce the function of Chameau, 
Tip60, MOF, or Gcn5 by RNAi in erm hypomorphic mutant brains, looking for 
enhancement of the supernumerary neurobalst phenotype. Once the HAT that most 
likely activates erm expressions is identified, we will determine whether the type II 
neuroblast specific activator network recruits this HAT to the poised erm enhancer. 
Briefly, HAT specific ChIP experiments will be performed on type II neuroblast enriched  
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Figure 25: Preliminary Data. (A-C) Confocal images comparing the expression of wild type 
dist5E-luc::rfp(nls) and dist5E mut Pnt-luc::gfp(nls) in type II neuroblast lineages. (D) Table 
summarizing the the conserved binding motifs for type II specific transcriptional activators in 
the erm distal immature INP enhancer. (E) Quantification of the number of supernumerary 
type II neuroblasts in erm hypomorphic mutant brains overexpressing RNAi transgenes 
targeting the indicated genes. (F-J) Confocal images of erm hypomorphic mutant brains 
overexpressing RNAi transgenes targeting the indicated genes. (K) Schematic 
representation of the erm locus showing the relative position of the erm immature INP 
enhancer and the erm PRE. Kb: kilobases. (L) ChIP analysis of the relative enrichment of 
H3K4me2 (red), H3K27me3 (blue), H3K27ac (green) and an IgG control (black) on the 
transcription start sites (TSS) and 12E9 enhancer of D from type II neuroblast enriched 
chromatin. (M-O) Confocal images showing the expression pattern of a -Gal(nls) reporter 
driven by the D 12E9 enhancer, as well as the ap 40C10 enhancer and opa 70B05 
enhancer. The ap 40C10 enhancer and opa 70B05 enhancer do not become expressed until 
an INP completes maturation. White arrow: type II neuroblast. White arrowhead: newly born 
immature INP and Ase- immature INP. Yellow arrow: Ase+ immature INP. Yellow arrowhead: 
INP. 
chromatin. Enrichment for the wild-type dist5E transgene, but not the inactive 
PntP1/Btd/Sp1/Dll mutant dist5E transgene, would indicate these transcription factors 
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mediate poised enhancer activation through this HAT. The identification of an 
alternative HAT that is functionally required for erm activation will provide an important 
revision to the model of poised enhancer activation.  
 Interestingly, from an unbiased genetic screen we found that heterozygous 
mutation of the loci containing encore (enc) and skuld (skd) both enhanced the 
supernumerary neuroblast phenotype in erm hypomorphic mutant brains (data not 
shown). We confirmed this genetic interaction by specifically knocking-down either enc 
or skd by RNAi (Figure 25E, F, I, J).  Interestingly, Enc and Skd are both components of 
the Mediator complex and have been shown to physically and genetically interact with 
TrxG and PcG genes in Drosophila (Guruharsha et al., 2011; Lindsley and Zimm, 1992). 
In mouse ES cells the Mediator complex facilitates enhancer-promoter interactions by 
physically stabilizing DNA looping (Kagey et al., 2010). The endogenous erm immature 
INP enhancer is located approximately 7kb from its promoter (Figure 25 K). Thus, an 
attractive possibility is that Skd and Enc facilitate this long range enhancer-promoter 
interaction to promote erm expression in immature INPs. To test this possibility 
experimentally we will perform a variation of the chromatin conformation capture 
technique, comparing the relative frequency of the enhancer-promoter interaction in a 
genetic background in which Skd and Enc are functional to a genetic background in 
which their function is reduced. In addition, we will perform a similar ChIP experiment to 
the one previously described, to examine whether type II specific transcription factors 
recruit Skd or Enc to the erm immature INP enhancer. Together these experiments will 
improve our understanding of the hierarchical relationship between transcription factor 
binding, chromatin modification and chromatin architecture during the activation of a 
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poised gene. This knowledge will likely provide novel strategies to manipulate stem cell 
function, and insight into the molecular mechanisms underlying numerous 
developmental pathologies.  
Clarifying the role of PcG genes during regulation of erm expression.  
The prevailing model is that by catalyzing H3K27me3 and repressing poised-
differentiation genes, PRC2 functions to maintain stem cell identity (Boyer et al., 2006; 
Heinz et al., 2015; Lee et al., 2006d). Paradoxically, we find that although the 
endogenous erm promoter and immature INP enhancer are marked by H3K27me3, 
PRC2 is not required to maintain erm repression, and instead erm expression is 
reduced or lost in PCR2 mutant immature INPs (Janssens et al., 2016) (see Chapter 3). 
This result suggests that, in contrast to the canonical role of PRC2, it may be required 
for activation of endogenous erm expression. In support of this model, several studies 
have reported a role for both PRC1 and PRC2 in mediating target gene activation 
(Ferrari et al., 2014; Frangini et al., 2013; Lv et al., 2016; Pasini et al., 2007). A recent 
study of Drosophila imaginal discs found genes that are activated versus repressed by 
PcG genes could be stratified based on the presence of mono-methylation of lysine 20 
on histone 4 (H4K20me1) in genes that require PRC2 for their activation (Lv et al., 
2016). Consistent with this observation, the H4K20 methyltransferase PR-Set7 was 
found to bind these PcG activated genes, and PR-Set7 was also required for their 
activation (Lv et al., 2016).  To follow up on the potential role of PRC2 during the 
activation of erm expression, we will examine whether knock-down of PR-Set7 or 
components of PRC2 enhances the supernumerary neuroblast phenotype in erm 
hypomorphic mutant brains. In addition, we will examine whether the endogenous erm 
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promoter and immature INP enhancer display H4K20me1 in type II neuroblast enriched 
chromatin. This work could potentially provide a mechanistic explanation for the context 
dependent function of PRC2 during the regulation of distinct poised genes, or even on 
the same poised gene in distinct stem cell types.   
It remains possible that the loss of erm expression in PRC2 mutants is the result 
of an indirect effect. To test whether PRC2 has a direct role during activation of erm 
expression we plan to specifically disrupt PRC2 recruitment to the erm locus, while 
leaving PRC2 itself intact. The mechanisms that recruit PcG proteins to specific regions 
of the genome in mammalian stem cells remain unclear, preventing examination of the 
isolated function of PcG proteins on specific poised loci. However, in Drosophila PcG 
genes are known to be recruited to their target loci through molecularly defined 
Polycomb Response Elements (PREs) (Ringrose and Paro, 2007). Indeed, previous 
genome-wide in silico studies identified a PRE in the erm locus (Figure 25K) (Ringrose 
et al., 2003).  To examine the function of PRC2 on the erm locus we will specifically 
knock out the PRE from the endogenous erm locus, creating the ermPRE mutant allele. If 
homozygous ermPRE mutants show a loss of endogenous erm expression, and 
recapitulate the supernumerary neuroblast phenotype of erm null brains, we will 
conclude PRC2 directly regulates activation of erm expression. This result would 
fundamentally change the current model of poised gene regulation and strongly 
encourage investigation of potential context dependent roles of PRC2.  
Interestingly, the transgenic dist5E reporter is not expressed in type II 
neuroblasts and becomes activate in immature INPs with very similar kinetics to 
endogenous erm, however, PRC2 is likely not recruited to this transgene because the 
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surrounding chromatin is not marked H3K27me3. Why might endogenous erm require 
PRC2 for activation, while a transgene bearing the erm immature INP enhancer does 
not? One obvious difference is that the erm enhancer in the transgenic reporter is 
positioned directly adjacent to the gene promoter, whereas in the endogenous erm 
locus the immature INP enhancer is located 7 kilobases upstream of the erm promoter 
(Figure 25K). Accumulating evidence suggests PcG genes have an important role in 
assembling the 3 dimensional architecture of the genome (Bantignies et al., 2011; 
Sexton and Cavalli, 2015; Sexton et al., 2012). Thus, an attractive possibility is that PcG 
genes may contribute to the long rang enhancer-promoter interaction on the erm locus.  
We will test this possibility using a combination of transgenic reporters and a variation of 
chromosome conformation capture to compare the enhancer-promoter interactions on 
the wild-type erm locus with enhancer-promoter interactions on the ermPRE mutant 
locus. This work has the potential to elucidate a novel function of PcG proteins during 
target gene regulation, and would suggest that, as opposed to directly promoting target 
gene activation versus repression per say, PcG genes are important to establish and 
maintain the proper confirmation of their target loci. 
Determining how distinct classes of poised genes are regulated.  
The precise specification of intermediate progenitor identity requires repression of stem 
cell self-renewal pathways and activation of the programs controlling intermediate 
progenitor specific functions, including the generation of specific differentiated cell 
types. However, the mechanisms coordinating this critical transition in cellular identity 
remain unclear in most stem cell lineages. Our work demonstrates that erm functions as 
a poised negative feedback circuit to ensure the maintenance of a restricted 
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intermediate progenitor identity by directly repressing components of the stem cell 
transcription factor network (Janssens et al., 2016) (see Chapter 3). Intriguingly, our 
preliminary data suggests that components of the temporal cascade that directs the 
generation of distinct types of neurons and glia through sequential round of INP division 
are also maintained in a poised state in type II neuroblasts. The D immature INP 
enhancer (12E9) and D promoter both display histone marks associated with poised 
genes (Figure 25L), and a transgene bearing the 12E9 enhancer activates reporter 
gene expression in a similar pattern to the erm immature INP enhancer (Figure 25M, 
M’). This suggests erm and D are likely regulated by a common class of fast-activating 
poised enhancers. Similar to the erm locus, the transcription factors opa and ap display 
high levels of H3K27me3 In S2 cells, suggesting these loci are also direct PRC2 targets 
(modencode). In addition, we identified an ap enhancer (40C10) and an opa enhancer 
(70B05) that don’t become activate until completion of INP maturation (Figure 25 N-O’). 
This preliminary data suggests opa and ap are likely regulated by a distinct class of 
poised enhancers.  
Our identification of distinct classes of poised genes provides an exciting 
opportunity to examine the regulatory mechanisms that contribute to their distinct 
expression patterns. For example, in mammalian adult NSC lineages the H3K27 
specific demethylase JMJD3 is required for robust activation of the poised gene Dlx2 in 
intermediate progenitors (Park et al., 2014). However, Utx, the Drosophila homologue of 
JMJD3, does not appear to play a functional role in erm activation (data not shown). 
Thus, we are interested in testing whether poised genes such as opa and ap, which are 
activated with slower kinetics, may require Utx for their activation, whereas fast-
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activating poised genes such as erm and D may not. Interestingly, the type II specific 
transcription factors pntP1 and btd are likely also maintained in a poised state, but 
become activated during the birth of a type II neurobalst. Once activated PntP1 and Btd 
likely contribute to priming the erm locus for activation in type II neuroblast progeny 
following asymmetric division. This suggests poised genes may form a relay mechanism 
to control the progressive restriction of developmental potential in stem cell lineages. By 
continuing to investigate the cell-type specific enhancers of pntP1, btd, erm, D, opa and 
ap, we hope to elucidate the regulatory mechanisms underlying this poised relay circuit. 
Lastly, we are interested in using a combination of in situ hybridization and chromosome 
confirmation capture to examine how distinct classes of poised genes are coordinated in 
the 3-dimensional space of the nucleus. PcG proteins have been shown to mediate 
functional inter-genic interactions between distal Hox clusters (Bantignies et al., 2011). 
Might poised genes that are expressed in type II neuroblasts, such as pntP1 and btd, be 
maintained in a different nuclear compartment from poised genes that are expressed in 
their immature INP progeny, such as erm and D, or mature INPs, such as opa and ap? 
This aspect of poised gene regulation remains completely unexplored, and has the 
potential to revolutionize our understanding of developmental relay mechanisms.  
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